<SEC-DOCUMENT>0001641172-25-019514.txt : 20250714
<SEC-HEADER>0001641172-25-019514.hdr.sgml : 20250714
<ACCEPTANCE-DATETIME>20250714161938
ACCESSION NUMBER:		0001641172-25-019514
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250714
FILED AS OF DATE:		20250714
DATE AS OF CHANGE:		20250714

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Greenwave Technology Solutions, Inc.
		CENTRAL INDEX KEY:			0001589149
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-METALS SERVICE CENTERS & OFFICES [5051]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				462612944
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41452
		FILM NUMBER:		251121924

	BUSINESS ADDRESS:	
		STREET 1:		4016 RAINTREE RD,
		STREET 2:		STE 300
		CITY:			CHESAPEAKE
		STATE:			VA
		ZIP:			23321
		BUSINESS PHONE:		(800) 490-5020

	MAIL ADDRESS:	
		STREET 1:		4016 RAINTREE RD,
		STREET 2:		STE 300
		CITY:			CHESAPEAKE
		STATE:			VA
		ZIP:			23321

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MassRoots, Inc.
		DATE OF NAME CHANGE:	20131011
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>formpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:GWAV="http://gwav.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_GWAV_gwav.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001589149 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001589149</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0010" name="dei:DocumentType">PRE 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gwav-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001589149</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_2024-04-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001589149</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
            <ecd:RestatementDateAxis.domain>2024-04-16</ecd:RestatementDateAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001589149</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001589149</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000038"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000038"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000038"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000034" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000035" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000036" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000037" toRefs="Footnote000046"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>UNITED STATES</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-size: 18pt"><b><span id="xdx_903_edei--DocumentType_dxL_c20240101__20241231_zGX53Ef2IUTd" title="::XDX::PRE%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE
14A</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>(RULE 14a-101)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Proxy Statement Pursuant
to Section 14(a) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Securities Exchange
Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Filed by the Registrant
<span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Filed by a Party other
than the Registrant <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Check the appropriate
box:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td><span style="font-size: 10pt">Preliminary Proxy Statement</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td><span style="font-size: 10pt"><b>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Definitive Proxy Statement</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td><span style="font-size: 10pt">Definitive Additional Materials</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td><span style="font-size: 10pt">Soliciting Material Pursuant to Rule Sec.240.14a-12</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20240101__20241231_zBeYCakYhjnj"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000011" name="dei:EntityRegistrantName">GREENWAVE
TECHNOLOGY SOLUTIONS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>(Name of Registrant
as Specified In Its Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>(Name of Person(s)
Filing Proxy Statement, if other than the Registrant)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td><span style="font-size: 10pt">No fee required</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td><span style="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td>
    <td><span style="font-size: 10pt">Title of each class of securities to which transaction applies:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(2)</span></td>
    <td><span style="font-size: 10pt">Aggregate number of securities to which transaction applies:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(4)</span></td>
    <td><span style="font-size: 10pt">Proposed maximum aggregate value of transaction:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(5)</span></td>
    <td><span style="font-size: 10pt">Total fee paid:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td><span style="font-size: 10pt">Fee paid previously with preliminary materials:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td>
    <td><span style="font-size: 10pt">Amount previously paid:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(2)</span></td>
    <td><span style="font-size: 10pt">Form, Schedule or Registration Statement No.:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(3)</span></td>
    <td><span style="font-size: 10pt">Filing Party:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(4)</span></td>
    <td><span style="font-size: 10pt">Date Filed:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Greenwave Technology Solutions, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">4016 Raintree Rd, Suite 300</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chesapeake, VA 23321</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(800) 490-5020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>To be Held on August
13, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">To the Stockholders of
Greenwave Technology Solutions, Inc.:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">NOTICE
IS HEREBY GIVEN that the 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Greenwave Technology Solutions, Inc.,
a Delaware corporation (the &#8220;Company&#8221;), will be held on August 13, 2025 at 4:30 p.m. Eastern Time. The Annual Meeting will
be a virtual meeting to be held as a listen-only conference call by calling 877-407-3088 (Toll Free) or by visiting www.GWAV.vote. There
will not be a physical meeting location. If you encounter any technical difficulties with the virtual meeting platform on the meeting
day, please call 877-804-2062 (toll free) or email proxy@equitystock.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
principal business of the meeting will be:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">To elect three directors to serve until the next annual meeting of stockholders or until their successors
are duly elected and qualified;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">To ratify the appointment of RBSM LLP as our independent registered public accounting firm for the fiscal
year ending December 31, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">3.</td><td style="text-align: justify">To approve, on an advisory and non-binding basis, the compensation paid to the Company&#8217;s named executive
officers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">4.</td><td style="text-align: justify">To approve on a non-binding advisory
                                            basis a three-year frequency for holding an advisory vote on executive compensation;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">5.</td><td style="text-align: justify">To approve the issuance of warrants to purchase up to an aggregate of 28,644,323 shares of the Company&#8217;s
common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), and the issuance of the shares of Common Stock issuable upon the
exercise of such warrants, in accordance with Listing Rule 5635(d) of The Nasdaq Stock Market LLC (&#8220;Nasdaq Listing Rule 5635(d)&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">6.</td><td style="text-align: justify">To approve the issuance of 11,346,743 shares of Common Stock issuable upon exercise of certain existing
warrants that were amended on January 10, 2025 to, among other things, increase the number of shares of Common Stock issuable upon exercise
of such warrants, in accordance with Nasdaq Listing Rule 5635(d);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">7.</td><td style="text-align: justify">To ratify the terms and approve the issuance of 450,000 shares of Series A-1 Convertible Preferred Stock
of the Company, par value $0.001 per share (the &#8220;Series A-1 Preferred Stock&#8221;), pursuant to the Contract of Sale, dated December
2, 2024 (the &#8220;Contract of Sale&#8221;), with DWM Properties LLC, KPAJ, LLC and Oceana Salvage Properties, L.L.C. (collectively,
the &#8220;Sellers&#8221;), in each case, an entity affiliated with Danny Meeks, the Company&#8217;s Chief Executive Officer and Chairman
of the Board, pursuant to which the Company agreed to purchase certain Premises (as defined in the Contract of Sale) held by the Sellers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">8.</td><td style="text-align: justify">To grant discretionary authority to the Company&#8217;s Board of Directors to amend the Certificate of
Incorporation to effect one or more consolidations of the issued and outstanding shares of Common Stock, pursuant to which the shares
of Common Stock would be combined and reclassified into one share of Common Stock at a ratio within the range from 1-for-2 up to 1-for-150
(each, a &#8220;Reverse Stock Split&#8221;), provided that, (X) the Company shall not effect Reverse Stock Splits that, in the aggregate,
exceed 1-for-150, and (Y) any Reverse Stock Split is completed no later than the second anniversary of the Record Date (as defined herein);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">9.</td><td style="text-align: justify">To approve the adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies
in favor of the foregoing proposals if there are not sufficient votes to approve the foregoing proposals; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">10.</td><td style="text-align: justify">To transact such other business as may be properly brought before the Annual Meeting and any adjournments
thereof.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
may vote if you were the record owner of shares of the Company&#8217;s Common Stock or Series A-1 Preferred Stock, at the close of business
on July 17, 2025. The Board of Directors of the Company has fixed the close of business on July 17, 2025 as the record date (the &#8220;Record
Date&#8221;) for the determination of holders of Common Stock (the &#8220;Common Stockholders&#8221;) and holders of Series A-1 Preferred
Stock (the &#8220;Series A-1 Preferred Stockholders&#8221;, and together with the Common Stockholders, the &#8220;Stockholders&#8221;)
entitled to notice of and to vote at the Annual Meeting and at any adjournments thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of the Record Date, there were 61,169,509 shares of Common Stock and 450,000 shares of Series A-1 Preferred Stock outstanding and entitled
to vote at the Annual Meeting. The Common Stockholders are entitled to one vote for each share of Common Stock held. The Series A-1 Preferred
Stockholders are entitled to one vote per share of Common Stock each holder would be entitled to receive upon conversion of their Series
A-1 Preferred Stock. The foregoing shares of Common Stock and Series A-1 Preferred Stock are referred to herein as the &#8220;Shares.&#8221;
Holders of our Common Stock and Series A-1 Preferred Stock will vote together as a single class on all matters described in this proxy
statement (the &#8220;Proxy Statement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Stockholders
are cordially invited to virtually attend the Annual Meeting. Whether you plan to virtually attend the Annual Meeting or not, you are
requested to vote over the Internet, by telephone, or to complete, sign, date and return the enclosed proxy card promptly in accordance
with the instructions set forth on the proxy card. A pre-addressed, postage prepaid return envelope is enclosed for your convenience.
Voting by using the aforementioned methods will not prevent you from voting virtually at the annual meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>YOUR VOTE AT THE ANNUAL MEETING IS IMPORTANT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Your vote is important. Please
vote as promptly as possible even if you plan to virtually attend the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For information on how to
vote your Shares, please see the instruction from your broker or other fiduciary, as applicable, as well as &#8220;How Do I Vote?&#8221;
in the Proxy Statement accompanying this notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We encourage you to vote over
the Internet, by telephone, or by completing, signing, and dating the proxy card, and returning it in the enclosed envelope.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you have questions about
voting your Shares, please contact our Chief Executive Officer at Greenwave Technology Solutions, Inc., at 4016 Raintree Rd, Suite 300,
Chesapeake, VA 23321, telephone number (800) 490-5020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you decide to change your
vote, you may revoke your proxy in the manner described in the attached Proxy Statement at any time before it is voted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We urge you to review the
accompanying materials carefully and to vote as promptly as possible. Note that we have enclosed with this notice a proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE PROXY STATEMENT AND THE ANNUAL REPORT ARE
AVAILABLE AT:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>www.GWAV.vote</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By Order of the Board of Directors
of Greenwave Technology Solutions, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 50%"><span style="font-size: 10pt">Sincerely,</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><i>/s/ Danny Meeks</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Danny Meeks, Chief Executive Officer and Chairman of the Board</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b><span style="text-decoration: underline">IMPORTANT
    NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON August 13, 2025</span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Notice of Annual Meeting of Stockholders,
    Annual Report on Form 10-K and our Proxy Statement are available at www.GWAV.vote</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REFERENCES TO ADDITIONAL INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Proxy Statement incorporates
important business and financial information about Greenwave Technology Solutions, Inc. that is not included in or delivered with this
document. You may obtain this information without charge through the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) website
(www.sec.gov) or upon your written or oral request by contacting the Chief Executive Officer of Greenwave Technology Solutions, Inc.,
at 4016 Raintree Rd, Suite 300, Chesapeake, VA 23321, telephone number (800) 490-5020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>To ensure timely delivery
of these documents prior to the Annual Meeting, any request should be made no later than August 6, 2025.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For additional details about
where you can find information about Greenwave Technology Solutions, Inc., please see the section entitled &#8220;Where You Can Find More
Information about the Company&#8221; in this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Greenwave Technology Solutions, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">4016 Raintree Rd, Suite 300</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chesapeake, VA 23321</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(800) 490-5020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>2025 ANNUAL MEETING
OF STOCKHOLDERS TO BE HELD ON AUGUST 13, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>GENERAL INFORMATION ABOUT THE ANNUAL MEETING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
Proxy Statement, along with the accompanying notice of the 2025 Annual Meeting of Stockholders, contains information about the 2025 Annual
Meeting of Stockholders of Greenwave Technology Solutions, Inc., including any adjournments or postponements thereof (referred to herein
as the &#8220;Annual Meeting&#8221;). We are holding the Annual Meeting at 4:30 pm Eastern Time on August 13, 2025 or such later date
or dates as such Annual Meeting date may be adjourned or postponed. The Annual Meeting will be a completely virtual meeting of Stockholders
conducted via live audio webcast to enable and encourage Stockholders to participate in the Annual Meeting from any location around the
world that is convenient to them. You will be able to attend the Annual Meeting by visiting www.GWAV.vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
this Proxy Statement, we refer to Greenwave Technology Solutions, Inc. as &#8220;Greenwave,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221;
&#8220;us,&#8221; or &#8220;our.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Why Did You Send Me
This Proxy Statement?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
sent you this Proxy Statement in connection with the solicitation by the board of directors of the Company (referred to herein as the
&#8220;Board of Directors&#8221; or the &#8220;Board&#8221;) of proxies, in the accompanying form, to be used at the Annual Meeting to
be held at 4:30 p.m. Eastern Time on August 13, 2025 and any adjournments thereof. This Proxy Statement along with the accompanying Notice
of Annual Meeting of Stockholders summarizes the purposes of the Annual Meeting and the information you need to know to vote at the Annual
Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Important Notice Regarding
the Availability of Proxy Materials for the Stockholder Meeting to Be Held on August 13, 2025. The Proxy Statement and annual report to
security holders are available at www.GWAV.vote.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
Proxy Statement is being mailed on or about July 24, 2025 to Stockholders entitled to notice of and to vote at the meeting. You can also
find a copy of our Annual Report on Form 10-K for the year ended December 31, 2024 (the &#8220;Annual Report&#8221;), which includes our
financial statements for the fiscal year ended December 31, 2024, by following the instructions contained in the Notice of Availability
mailed to Stockholders entitled to notice of and to vote at the meeting along with this Proxy Statement on August 13, 2025, or on the
Internet through the SEC&#8217;s electronic data system at <i>www.sec.gov </i>or at <i>www.GWAV.com.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who may attend and how to attend?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has fixed the close
of business on July 17, 2025 as the Record Date. Each share of Common Stock represents one vote to be voted on each matter presented at
the Annual Meeting. Each share of Series A-1 Preferred Stock is entitled to vote on an as-converted basis and is convertible into Common
Stock at 0.0001% of the then-outstanding shares of Common Stock, having voting weight equal to 45% of the number of shares of Common Stock
outstanding. Record holders and beneficial owners may attend the Annual Meeting via phone. Set forth below is a summary of the information
you need to attend the virtual Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
    <td style="width: 24px">&#160;</td>
<td style="width: 24px; text-align: left">&#9679;</td><td style="text-align: justify">Access an audio-only conference call by calling 877-407-3088 (Toll Free) or +1 877-407-3088
(International).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
    <td style="width: 24px">&#160;</td>
<td style="width: 24px; text-align: left">&#9679;</td><td style="text-align: justify">Instructions on how to attend and participate in the virtual Annual Meeting, including
how to demonstrate proof of stock ownership, are also available as follows:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stockholders of Record</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Stockholders of record as of the Record Date can attend the Annual Meeting by accessing the live audio conference call at +1-877-407-3088 and presenting the unique 12-digit control number on the proxy card.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Beneficial Owners</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If you were a beneficial owner of record as of the Record Date (i.e., you held your Shares in an account at a brokerage firm, bank or other similar agent), you will need to obtain a legal proxy from your broker, bank or other agent. Once you have received a legal proxy from your broker, bank or other agent, it should be emailed to our transfer agent, Equity Stock Transfer, at proxy@equitystock.com and should be labeled &#8220;Legal Proxy&#8221; in the subject line. Please include proof from your broker, bank or other agent of your legal proxy (e.g., a forwarded email from your broker, bank or other agent with your legal proxy attached, or an image of your valid proxy attached to your email). Requests for registration must be received by Equity Stock Transfer no later than 5:00 p.m. Eastern Time on August 11, 2025. You will then receive a confirmation of your registration, with a control number, by email from Equity Stock Transfer. At the time of the meeting, access the live audio conference call at +1-877-407-3088 and present your unique 12-digit control number. </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Stockholders may submit live questions on the conference line while attending the virtual Annual Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What if I have technical difficulties or trouble
accessing the virtual Annual Meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will have technicians ready
to assist you with any technical difficulties you may have in accessing the virtual Annual Meeting. If you encounter any difficulties,
please call: 877-804-2062 (Toll Free) or email proxy@equitystock.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Why is the 2025 Annual
Meeting a virtual, online meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">We believe hosting the Annual
Meeting virtually will enable increased Stockholder attendance and will encourage more active Stockholder engagement and participation
at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Who Can Vote?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Stockholders
who owned Shares at the close of business on the Record Date are entitled to vote at the Annual Meeting. As of the Record Date, there
were 61,169,509 shares of Common Stock and 450,000 shares of Series A-1 Preferred Stock outstanding and entitled to vote at the Annual
Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
do not need to virtually attend the Annual Meeting to vote your Shares. Shares represented by valid proxies, received in time for the
Annual Meeting and not revoked prior to the Annual Meeting, will be voted at the Annual Meeting. Stockholders may revoke a proxy before
the proxy is voted by delivering to our Secretary a signed statement of revocation or a duly executed proxy card bearing a later date.
Any Stockholder who has executed a proxy card but attends the Annual Meeting virtually may revoke their proxy by voting at the Annual
Meeting. See &#8220;<i>May I Change or Revoke My Proxy?</i>&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>How Many Votes Do
I Have?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Each
holder of Common Stock is entitled to one vote per share of Common Stock. Each holder of Series A-1 Preferred Stock is entitled to one
vote per share of Common Stock each holder would be entitled to receive upon conversion of their Series A-1 Preferred Stock, having voting
weight equal to 45% of the number of shares of Common Stock outstanding. Holders of our Common Stock and Series A-1 Preferred Stock will
vote together as a single class.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>How Do I Vote?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Whether
you plan to virtually attend the Annual Meeting or not, we urge you to vote by proxy. All Shares represented by valid proxies that we
receive through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the proxy card or as
instructed via Internet or telephone. You may specify whether your Shares should be voted for or against each nominee for director, and
whether your Shares should be voted for, against or abstain with respect to each of the other proposals. Except as set forth below, if
you properly submit a proxy without giving specific voting instructions, your Shares will be voted in accordance with the Board&#8217;s
recommendations as noted below. Voting by proxy will not affect your right to virtually attend the Annual Meeting. If your Shares are
registered directly in your name through our stock transfer agent, Equity Stock Transfer, or you have stock certificates, you may vote:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>By Internet or by telephone.</b> Follow the instructions you received to vote by Internet or telephone.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>By mail.</b> Complete and mail the enclosed proxy card in the enclosed postage prepaid envelope. Your proxy will be voted in accordance with your instructions. If you sign the proxy card but do not specify how you want your Shares voted, they will be voted as recommended by the Board.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
your Shares are held in &#8220;street name&#8221; (held in the name of a bank, broker or other nominee), you must provide the bank, broker
or other nominee with instructions on how to vote your Shares and can do so as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>By Internet or by telephone.</b> Follow the instructions you receive from your broker to vote by Internet or telephone.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>By mail.</b> You will receive instructions from your broker or other nominee explaining how to vote your Shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a beneficial owner
of Shares held in street name and do not provide the organization that holds your Shares with specific voting instructions, under the
rules of various national and regional securities exchanges, the organization that holds your Shares may generally vote on routine matters,
but cannot vote on non-routine matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>How Does the Board
Recommend that I Vote on the Proposals?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Board recommends that you vote on the proposals presented herein as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td>&#8220;<b>FOR</b>&#8221; the election of the Board nominees as directors;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 5.25pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the ratification of the selection of RBSM LLP as our independent registered public
accounting firm for the fiscal year ending December 31, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><b>&#8220;FOR&#8221;</b> the approval, on an advisory and non-binding basis, of the compensation paid to our named executive officers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; approval,
                                            on a non-binding advisory basis, of a three-year frequency for holding an advisory vote on
                                            executive compensation;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.75in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the issuance of warrants to purchase up to an aggregate of 28,644,323 shares
of the Company&#8217;s Common Stock, and the issuance of the shares of Common Stock issuable upon the exercise of such warrants, in accordance
with Nasdaq Listing Rule 5635(d);&#160;&#160;&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the issuance of 11,346,743 shares of Common Stock issuable upon exercise of certain
existing warrants that were amended on January 10, 2025 to, among other things, increase the number of shares of Common Stock issuable
upon exercise of such warrants, in accordance with Nasdaq Listing Rule 5635(d);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: 0.75in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the ratification of the terms and approval of the issuance of 450,000 shares of the Series A-1 Preferred
Stock pursuant to the Contract of Sale with the Sellers, in each case, an entity affiliated with Danny Meeks, the Company&#8217;s Chief
Executive Officer and Chairman of the Board, pursuant to which the Company agreed to purchase certain Premises (as defined in the Contract
of Sale) held by the Sellers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the grant of discretionary authority to the Company&#8217;s Board to amend the
Certificate of Incorporation to effect one or more consolidations of the issued and outstanding shares of Common Stock, pursuant to which
the shares of Common Stock would be combined and reclassified into one share of Common Stock at a ratio within the range from 1-for-2
up to 1-for-150 (each, a &#8220;Reverse Stock Split&#8221;), provided that, (X) the Company shall not effect Reverse Stock Splits that,
in the aggregate, exceed 1-for-150, and (Y) any Reverse Stock Split is completed no later than the second anniversary of the Record Date
(as defined herein); and&#160;&#160;&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the approval of the adjournment of the Annual Meeting, if necessary or advisable,
to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the foregoing proposals.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
any other matter is presented, the proxy card provides that your Shares will be voted by the proxy holder listed on the proxy card in
accordance with his or her best judgment. At the time this Proxy Statement was printed, we knew of no matters that needed to be acted
on at the Annual Meeting, other than those discussed in this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>May I Change or Revoke
My Proxy?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
you give us your proxy, you may change or revoke it at any time before the Annual Meeting. You may change or revoke your proxy in any
one of the following ways:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">by signing a new proxy card and submitting it as instructed above;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">by re-voting by Internet or by telephone as instructed above &#8212; only your latest Internet or telephone vote will be counted;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">if your Shares are registered in your name, by notifying the Company&#8217;s Secretary in writing before the Annual Meeting that you
have revoked your proxy; or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">by virtually attending the Annual Meeting and voting; however, virtually attending the Annual Meeting will not in and of itself revoke
a previously submitted proxy unless you specifically request it.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>What If I Receive
More Than One Proxy Card?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
may receive more than one proxy card or voting instruction form if you hold Shares in more than one account, which may be in registered
form or held in street name. Please vote in the manner described under &#8220;How Do I Vote?&#8221; on the proxy card for each account
to ensure that all of your Shares are voted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>What is a Broker Non-Vote?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
your Shares are held in a fiduciary capacity (typically referred to as being held in &#8220;street name&#8221;), you must instruct the
organization that holds your Shares how to vote your Shares. If you sign your proxy card but do not provide instructions on how your broker
should vote on &#8220;routine&#8221; proposals, your broker will vote your Shares as recommended by the Board. If you do not provide voting
instructions, your Shares will not be voted on any &#8220;non-routine&#8221; proposals. This vote is called a &#8220;broker non-vote.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>What Vote is Required
to Approve Each Proposal and How are Votes Counted?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 32%"><span style="font-size: 10pt"><b>Proposal 1: Election of Directors</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 66%; text-align: justify"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares cast (virtually or represented by proxy) on the subject matter at the Annual Meeting is required to elect nominees as directors. Abstentions are not considered Shares cast for this proposal, and thus, will have no effect on the vote for this proposal. Broker non-votes will have no effect on the outcome of this proposal.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal 2: Ratification of the appointment of RBSM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required to ratify the appointment of RBSM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. This means that the votes cast by the Stockholders &#8220;FOR&#8221; the approval of the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; the approval of the proposal. If a Stockholder votes to &#8220;ABSTAIN,&#8221; it has the same effect as a vote &#8220;AGAINST.&#8221; If you are a beneficial owner, your broker, bank or other nominee may vote your Shares on this proposal without receiving voting instructions from you. </span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 32%"><span style="font-size: 10pt"><b>Proposal 3: Non-binding advisory vote to approve executive compensation.</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 66%"><span style="font-size: 10pt">To be approved, this non-binding advisory vote must be approved by a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting. This means that the votes cast by the Stockholders &#8220;FOR&#8221; the approval of the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; the approval of the proposal. If a Stockholder votes to &#8220;ABSTAIN,&#8221; it has the same effect as a vote &#8220;AGAINST.&#8221; Broker non-votes will have no effect on the outcome of this proposal.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal 4: Approval, on a non-binding advisory basis, of a three-year
    frequency for holding an advisory vote on executive compensation</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">While Proposal 4 is advisory in nature and nonbinding, the Board will review the voting results and expects to take them into consideration when determining the frequency for holding an advisory vote on executive compensation</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal 5: To approve the issuance of warrants to purchase up to an aggregate of 28,644,323 shares of Common Stock, and the issuance of the shares of Common Stock issuable upon the exercise of such warrants, in accordance with Nasdaq Listing Rule 5635(d);</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required to approve this proposal. This means that the votes cast by the Stockholders &#8220;FOR&#8221; the approval of the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; the approval of the proposal. If a Stockholder votes to &#8220;ABSTAIN,&#8221; it has the same effect as a vote &#8220;AGAINST.&#8221; Broker non-votes will have no effect on the outcome of this proposal.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;<b>Proposal 6: To approve the issuance of 11,346,743 shares of Common Stock issuable upon exercise of certain existing warrants that were amended on January 10, 2025 to, among other things, increase the number of shares of Common Stock issuable upon exercise of such warrants, in accordance with Nasdaq Listing Rule 5635(d);</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required to approve this proposal. This means that the votes cast by the Stockholders &#8220;FOR&#8221; the approval of the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; the approval of the proposal. If a Stockholder votes to &#8220;ABSTAIN,&#8221; it has the same effect as a vote &#8220;AGAINST.&#8221; Broker non-votes will have no effect on the outcome of this proposal.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal 7: To ratify the terms and approve the issuance of 450,000 shares of the Series A-1 Preferred Stock, pursuant to the Contract of Sale with the Sellers, in each case, an entity affiliated with Danny Meeks, the Company&#8217;s Chief Executive Officer and Chairman of the Board, pursuant to which the Company agreed to purchase certain Premises (as defined in the Contract of Sale) held by the Sellers; and</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required to approve this proposal. This means that the votes cast by the Stockholders &#8220;FOR&#8221; the approval of the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; the approval of the proposal. If a Stockholder votes to &#8220;ABSTAIN,&#8221; it has the same effect as a vote &#8220;AGAINST.&#8221; Broker non-votes will have no effect on the outcome of this proposal.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 32%"><span style="font-size: 10pt"><b>Proposal 8: To grant discretionary authority to the Company&#8217;s Board of Directors to amend the Certificate of Incorporation to effect one or more consolidations of the issued and outstanding shares of Common Stock, pursuant to which the shares of Common Stock would be combined and reclassified into one share of Common Stock at a ratio within the range from 1-for-2 up to 1-for-150 (each, a &#8220;Reverse Stock Split&#8221;), provided that, (X) the Company shall not effect Reverse Stock Splits that, in the aggregate, exceed 1-for-150, and (Y) any Reverse Stock Split is completed no later than the second anniversary of the Record Date (as defined herein).</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 66%"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting and entitled to vote as of the record date is required to approve the grant of discretionary authority to the Company&#8217;s Board of Directors to amend the Certificate of Incorporation to effect one or more consolidations of the issued and outstanding shares of Common Stock, pursuant to which the shares of Common Stock would be combined and reclassified into one share of Common Stock at a ratio within the range from 1-for-2 up to 1-for-150 (each, a &#8220;Reverse Stock Split&#8221;), provided that, (X) the Company shall not effect Reverse Stock Splits that, in the aggregate, exceed 1-for-150, and (Y) any Reverse Stock Split is completed no later than the second anniversary of the Record Date (as defined herein). Thus, abstentions and broker non-votes will have the same effect as a vote &#8220;AGAINST&#8221; this proposal.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt"><b>Proposal 9: Authorization to adjourn the Annual Meeting.</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">The affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required to approve this proposal. This means that the votes cast by the Stockholders &#8220;FOR&#8221; the approval of the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; the approval of the proposal. If a Stockholder votes to &#8220;ABSTAIN,&#8221; it has the same effect as a vote &#8220;AGAINST.&#8221; Broker non-votes will have no effect on the outcome of this proposal. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>What Constitutes a
Quorum for the Annual Meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
presence, virtually or by proxy, of the holders of a majority of the outstanding shares of each class or series of voting stock then entitled
to vote at the Annual Meeting constitutes a quorum at the Annual Meeting. Votes of Stockholders of record who are present at the virtual
Annual Meeting virtually or by proxy, abstentions, and broker non-votes are counted for purposes of determining whether a quorum exists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Do I Have Dissenters&#8217; Rights of Appraisal?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Stockholders do not have
appraisal rights under Delaware law or under the Company&#8217;s governing documents with respect to the matters to be voted upon at the
Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Householding of Annual
Disclosure Documents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
SEC previously adopted a rule concerning the delivery of annual disclosure documents. The rule allows us or brokers holding our Shares
on your behalf to send a single set of our annual report and proxy statement to any household at which two or more of our Stockholders
reside, if either we or the brokers believe that the Stockholders are members of the same family. This practice, referred to as &#8220;householding,&#8221;
benefits both Stockholders and us. It reduces the volume of duplicate information received by you and helps to reduce our expenses. The
rule applies to our annual reports, proxy statements and information statements. Once Stockholders receive notice from their brokers or
from us that communications to their addresses will be &#8220;householded,&#8221; the practice will continue until Stockholders are otherwise
notified or until they revoke their consent to the practice. Each Stockholder will continue to receive a separate proxy card or voting
instruction card.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Those
Stockholders who either (i) do not wish to participate in &#8220;householding&#8221; and would like to receive their own sets of our annual
disclosure documents in future years or (ii) who share an address with another one of our Stockholders and who would like to receive only
a single set of our annual disclosure documents should follow the instructions described below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Stockholders whose Shares are registered in their own name should contact our transfer agent, Equity Stock
Transfer, and inform them of their request by calling them at (212) 575-5757 or writing them at 237 W 37th Suite 602, New York, NY 10018.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Stockholders whose Shares are held by a broker or other nominee should contact such broker or other nominee
directly and inform them of their request. Stockholders should be sure to include their name, the name of their brokerage firm and their
account number.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who is Paying for this Proxy Solicitation?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company is paying the cost of preparing, printing and mailing these proxy materials. In addition to mailed proxy materials, our directors,
officers and employees may also solicit proxies in person, by telephone, or by other means of communication. We will not pay our directors,
officers and employees any additional compensation for soliciting proxies. We may reimburse brokerage firms, banks and other agents for
the cost of forwarding proxy materials to beneficial owners. We do not intend, but reserve the right, to use the services of a third party
solicitation firm to assist us in soliciting proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who will Count the Votes?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A representative from Equity
Stock Transfer, LLC will act as the inspector of election and count the votes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>When are Stockholder
Proposals due for the 2026 Annual Meeting of Stockholders?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">At
our annual meeting each year, our Board submits to Stockholders its nominees for election as directors. In addition, the Board may
submit other matters to the Stockholders for action at the annual meeting. Our Second Amended and Restated Bylaws (the
&#8220;Bylaws&#8221;) require advance notice of any proposal by a stockholder intended to be presented at an annual meeting that is
not included in our notice of annual meeting and proxy statement because it was not timely submitted, or made by or at the direction
of any member of the Board of Directors, including any proposal for the nomination for election as a director. To be considered for
such presentation at the 2026 annual meeting, stockholders of record intending to propose business must deliver notice in writing no
later than May 15, 2026, but no earlier than April 15, 2026, to the Company at Attention: Secretary/Chief Executive Officer,
Greenwave Technology Solutions, Inc., 4016 Raintree Rd, Suite 300, Chesapeake, VA 23321.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Stockholders may present proper
proposals for inclusion in the Company&#8217;s proxy statement for consideration at the 2026 annual meeting of stockholders by submitting
their proposals to the Company in a timely manner. These proposals must meet the stockholder eligibility and other requirements of the
SEC. To be considered for inclusion in next year&#8217;s proxy materials under Rule 14a-8, you must submit your proposal in writing no
later than March 26, 2026 to the Company at Attention: Chief Executive Officer, Greenwave Technology Solutions, Inc., 4016 Raintree
Rd, Suite 300, Chesapeake, VA 23321; provided, however, if the date of the 2026 annual meeting is convened more than 30 days before, or
delayed by more than 30 days after, the first anniversary of this Annual Meeting, a stockholder proposal must be submitted in writing
to the Company within a reasonable time before the Company prints and mails its proxy materials to stockholders for the 2026 annual meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>What Interest Do Executive
Officers and Directors Have in Matters to Be Acted Upon?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">None
of the members of the Board and none of the executive officers of the Company have any interest in any proposal that is not shared by
all other Stockholders of the Company except for Proposal No. 1 regarding the nomination of members to the Board, Proposal No. 3 regarding
the advisory vote on executive compensation, and Proposal No. 7 regarding ratification of the terms and approval of the issuance of 450,000
shares of Series A-1 Preferred Stock, pursuant to the Contract of Sale with the Sellers, in each case, an entity affiliated with Danny
Meeks, our Chief Executive Officer, pursuant to which the Company agreed to purchase certain Premises (as defined in the Contract of Sale)
held by the Sellers.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Where Can I Find the Voting Results of the
Annual Meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will announce preliminary
voting results at the Annual Meeting. We will also disclose voting results in a current report on Form 8-K filed with the SEC within four
business days after the Annual Meeting, which will be available on our website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WHERE YOU CAN FIND MORE INFORMATION ABOUT THE
COMPANY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company files annual,
quarterly and current reports, proxy statements and other information with the SEC. You can read and copy any materials that the Company
files with the SEC, which you can access over the Internet at http://www.sec.gov. The Company&#8217;s website address is www.GWAV.com.
Information contained on, or that can be accessed through, the Company&#8217;s website is not a part of this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
following table sets forth certain information regarding the beneficial ownership of our Common Stock by (i) each person who, to our knowledge,
owns more than 5% of our Common Stock (ii) our current directors and the named executive officers identified under the heading &#8220;Executive
Compensation&#8221; and (iii) all of our current directors and executive officers as a group. We have determined beneficial ownership
in accordance with applicable rules of the SEC, and the information reflected in the table below is not necessarily indicative of beneficial
ownership for any other purpose. Under applicable SEC rules, beneficial ownership includes any shares as to which a person has sole or
shared voting power or investment power and any shares which the person has the right to acquire within 60 days after July 11, 2025 through
the exercise of any option, warrant or right or through the conversion of any convertible security. Unless otherwise indicated in the
footnotes to the table below and subject to community property laws where applicable, we believe, based on the information furnished to
us that each of the persons named in this table has sole voting and investment power with respect to the shares indicated as beneficially
owned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in the table below is based on 61,169,509 shares of our Common Stock and 450,000 shares of Series A-1 Preferred Stock issued and outstanding
as of July 11, 2025. In computing the number of shares of Common Stock and Series A-1 Preferred Stock beneficially owned by a person
and the percentage ownership of that person, we deemed to be outstanding all shares of Common Stock subject to options, warrants, rights
or other convertible securities (including the Series A-1 Preferred Stock) held by that person that are currently exercisable or will
be exercisable within 60 days after July 11, 2025. We did not deem these shares outstanding, however, for the purpose of computing the
percentage ownership of any other person. Unless otherwise indicated, the principal address of each of the Stockholders below is in care
of Greenwave Technology Solutions, Inc., 4016 Raintree Rd, Chesapeake, VA 23321.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">Number of Shares<br/> of Common Stock<br/> Beneficially Owned</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Percentage of<br/> Common Stock<br/> Outstanding</b><sup>(1)</sup></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">% of Total<br/> Voting Power</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Directors and Named Executive Officers</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-size: 10pt; text-align: left">Danny Meeks</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 14%; font-size: 10pt; text-align: right">50,047,780</td><td style="width: 1%; font-size: 10pt; text-align: left"><sup>(2)</sup></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 14%; font-size: 10pt; text-align: right">3.5</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 14%; font-size: 10pt; text-align: right">45.0</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Lisa Lucas-Burke</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Cheryl Lanthorn</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">300,006</td><td style="font-size: 10pt; text-align: left"><sup>(3)</sup></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">*</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">*</span></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">All directors and named executive officers as a group (3 people)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">50,347,786</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4.0</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">45.3</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Other 5% Stockholder</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Joseph Reda<sup>(4)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,500,000</td><td style="font-size: 10pt; text-align: left"><sup>(5)</sup></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7.4</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4.1</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Anson Funds Management LP<sup>(6)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,843,160</td><td style="font-size: 10pt; text-align: left"><sup>(7)</sup></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7.9</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4.4</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">* Represents beneficial
ownership of less than 1.0% of our outstanding Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) For this column, the numerator is the number of outstanding shares
of Common Stock held by the reporting person and the denominator is equal to the total number of shares of Common Stock outstanding (61,169,509).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(2) Consists of
(i) 2,135,788 shares of Common Stock, (ii) 5,484 shares of Common Stock underlying warrants, and (iii) 47,906,508 shares of Common Stock
issuable upon conversion of 450,000 shares of Series A-1 Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(3) Includes 6 shares
owned by the reporting person&#8217;s spouse.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(4) The address
for Joseph Reda is 1324 Manor Circle Pelham, NY 10803.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(5) Based on a Schedule
13G filed by the Stockholder on February 13, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(6) The address
for Anson Funds Management LP is 16000 Dallas Parkway, Suite 800 Dallas, Texas 75248.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(7) Based on a Schedule
13G filed by the Stockholder on May 15, 2025.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL ONE:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ELECTION OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">At
this Annual Meeting, three (3) people, comprising the entire membership of the Board, are to be elected. The elected directors will serve
until the Company&#8217;s next annual meeting of Stockholders or until their successors are elected and qualified. Each of the nominees
currently serves on the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
nominees have consented to serve if elected. We expect that the nominees will be available for election, but if they are not candidates
at the time the election occurs, such proxy will be voted for the election of another nominee to be designated by the Board to fill any
such vacancy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term of office of the people elected as directors will continue until the next annual meeting or until their successor has been elected
and qualified, or until the director&#8217;s death, resignation or removal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Biographical
and certain other information concerning the Company&#8217;s nominees for election to the Board is set forth below. Our directors are
not directors in any other reporting companies. We are not aware of any proceedings to which our directors, or any associate of our directors
are a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="width: 30%"><span style="font-size: 10pt">Danny Meeks</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font-size: 10pt">52</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 51%; text-align: center"><span style="font-size: 10pt">Chief Executive Officer, Chairman of the Board</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Cheryl Lanthorn</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">54</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Lisa Lucas-Burke</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">61</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Mr. Danny Meeks</b>, <b>Chief
Executive Officer and Chairman of the Board </b>&#8211; Mr. Meeks is the Chief Executive Officer of the Company, a position he has held
since September 30, 2021. He has served as a director and Chairman of the Board since June 2021. He has served as interim Chief Financial
Officer from November 30, 2021 until April 18, 2022. He was the sole owner and President of Empire Services, Inc., a metal recycling company
he founded in 2002, until its acquisition by the Company in September 2021. Additionally, Mr. Meeks has been serving as the President
of DWM Properties, LLC, his real estate holding company, since 2002 and as the President of Select Recycling and Waste Services, Inc.,
a waste disposal and recycling company, from October 2016 to present. Mr. Meeks graduated from Manor High School in 1993. Mr. Meeks is
well-suited to serve on our Board due to his significant business and management experience and deep knowledge of growth and commercialization
strategies. Mr. Meeks joined the Company&#8217;s Board to foster revenue-generating capabilities of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Mrs. Cheryl Lanthorn, Director</b>
&#8211; Mrs. Lanthorn has served as a Director of the Company since April 2022. Mrs. Lanthorn began her career as a Personal Administrator
at Welton, Duke &amp; Hawks before rising to an Accounting Administrator due to her work-ethic, extensive accounting knowledge, and attention
to detail. For the next 14 years, Mrs. Lanthorn was a Software Trainer and Content Developer for Applied Systems, Inc., where she created
webinars and instructional documentation to teach employees how to best utilize TAM, Vision, Epic, and other scalable software programs.
From December 2015 to July 2022, Mrs. Lanthorn served as an Account Executive at Brown &amp; Brown Insurance, where she managed one of
the company&#8217;s largest books of business, managed employees and their books, trained new employees, and performed various other administrative
duties. Since August 2022, Mrs. Lanthorn has been a Senior Account Manager at Marsh McLennan Agency, LLC, where she manages large corporate
accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>Ms.
Lisa Lucas-Burke, Director</b> - Ms. Lucas-Burke has served as a Director of the Company since January 2025. Ms. Lucas-Burke began her
career with the City of Portsmouth in the Information Technology Department in 1988, ultimately as a Computer Programmer Analyst. In 2000,
Ms. Lucas-Burke joined her family business of Lucas Lodge, where she currently serves as Executive Director and business partner with
her mother, Senator L. Louise Lucas. Lucas-Burke was appointed to the Economic Development Authority in 2010 by the City Council, where
she was an EDA Commissioner for 6 years and ultimately achieved the position of Chairman of the Board. Ms. Lucas-Burke was elected to
Portsmouth City Council in 2016 and was re-elected in 2020. During Lucas-Burke&#8217;s eight-year tenure on the Portsmouth City Council,
she was unanimously voted in twice to serve as Vice Mayor by her City Council Colleagues. A graduate of Norfolk State University, Ms.
Lucas-Burke holds a Bachelor of Science Degree in Electronics Engineering (1987) and a Bachelor of Arts Degree in Psychology (2016). Ms.
Lucas-Burke is a Diamond Life Member of Delta Sigma Theta Sorority, Incorporated, and her chapter affiliation has been with the Portsmouth
Alumnae Chapter of Delta Sigma Theta Sorority, Inc., since 1996. Lucas-Burke served as Chapter President of Portsmouth Alumnae Chapter
for two, two-years terms (2008 &#8211; 2012); Lucas-Burke is also a member of the Portsmouth (VA) Chapter of The Links, Incorporated (2017
&#8211; present); Martin Luther King, Jr., Leadership Steering Committee (2006 &#8211; present); Portsmouth Democratic Committee (2006
&#8211; present); Lefcoe Trustee Board (2013 &#8211; present); Member of St. Mark Missionary Baptist Church (2009 &#8211; present); and
Lucas-Burke is also a former board member and Chair of The Portsmouth Boulevard &#8211; Center for Youth (2006 &#8211; 2012), where she
served as member, Treasurer and President over her six year term on the board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no family relationships
among our directors and executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Insider Trading Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
have an <span id="xdx_901_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240101__20241231_zgJR9CrxzR52" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000012" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">insider trading policy</ix:nonNumeric></span> that governs the purchase, sale, and other disposition of our securities by our directors, officers, employees
and other individuals associated with us, as well as by the Company itself, that we believe is reasonably designed to promote compliance
with insider trading laws, rules and regulations, and listing standards applicable to us. A copy of our insider trading policy is filed
as Exhibit 19.1 to Amendment No. 1 to our Annual Report on Form 10-K for the year ended December 31, 2024. The Company has no policy regarding
hedging the economic risks of equity ownership for the executive team or directors of the Company and the Company does not engage in this
practice.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Recovery Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_905_eecd--RestatementDoesNotRequireRecoveryTextBlock_c20240101__20241231__ecd--RestatementDateAxis__2024-04-16_zIj1oz01dm3a" class="xdx_phnt_RGlzY2xvc3VyZSAtIFJlY292ZXJ5IG9mIEVycm9uZW91c2x5IEF3YXJkZWQgQ29tcGVuc2F0aW9uAA__"><ix:nonNumeric contextRef="From2024-01-012024-12-31_2024-04-16" escape="true" id="Fact000013" name="ecd:RestatementDoesNotRequireRecoveryTextBlock">Our Board has adopted a compensation
recovery policy, which provides that in the event we are required to prepare an accounting restatement due to noncompliance with any financial
reporting requirements under the securities laws or otherwise erroneous data or we determine there has been a significant misconduct that
causes financial or reputational harm, we shall recover a portion or all of any incentive compensation. The policy is filed as an exhibit
to this annual report.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Changes to security holder director nomination procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has not adopted procedures for considering
director candidates submitted by stockholders under Item 407(c)(2)(iv), Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Involvement in Legal
Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">We are not aware of any of our directors or officers
being involved in any legal proceedings in the past ten years relating to any matters in bankruptcy, insolvency, criminal proceedings
(other than traffic and other minor offenses) or being subject to any of the items set forth under Item 401(f) of Regulation S-K.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required and
Board of Directors&#8217; Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The affirmative vote
of a majority of the Shares cast (virtually or represented by proxy) on the subject matter at the Annual Meeting is required to elect
nominees as directors. Abstentions are not considered Shares cast for this proposal, and thus, will have no effect on the vote for this
proposal. Broker non-votes will have no effect on the outcome of this proposal.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>THE BOARD RECOMMENDS
A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; THE ELECTION OF THE NOMINEES NAMED ABOVE, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF
UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THEIR PROXY CARD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CORPORATE GOVERNANCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Governance of Our
Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
seek to maintain high standards of business conduct and corporate governance, which we believe are fundamental to the overall success
of our business, serving our Stockholders well and maintaining our integrity in the marketplace. Our corporate governance guidelines and
Code of Conduct and Ethics, together with our Second Amended and Restated Certificate of Incorporation, Bylaws and the charters for each
of our Board committees, form the basis for our corporate governance framework. We also are subject to certain provisions of the Sarbanes-Oxley
Act and the rules and regulations of the SEC. The full text of the Code of Conduct and Ethics is available on our website at https://www.GWAV.com/code-of-conduct
and is also filed as an exhibit to our Annual Report on Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described below, our Board
has established four standing committees to assist it in fulfilling its responsibilities to the Company and its stockholders: the Audit
Committee, the Compensation Committee, the Sustainability Committee and the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Our Board of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of the date of this Proxy Statement, our Board consists of three members. The number of directors on our Board can be evaluated and amended
by action of our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board judges the independence
of its directors by the standards established by the Nasdaq Stock Market (&#8220;Nasdaq&#8221;). Accordingly, the Board has determined
that our two non-employee directors, Cheryl Lanthorn and Lisa Lucas-Burke each meet the independence standards established by Nasdaq and
the applicable independence rules and regulations of the SEC, including the rules relating to the independence of the members of our Audit
Committee and Compensation Committee. Our Board considers a director to be independent when the director is not an officer or employee
of the Company or its subsidiaries, does not have any relationship which would, or could reasonably appear to, materially interfere with
the independent judgment of such director, and the director otherwise meets the independence requirements under the listing standards
of the Nasdaq Stock Market and the rules and regulations of the SEC.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board believes its members
collectively have the experience, qualifications, attributes and skills to effectively oversee the management of our Company, including
a high degree of personal and professional integrity, an ability to exercise sound business judgment on a broad range of issues, sufficient
experience and background to resolve the issues facing our Company, a willingness to devote the necessary time to their Board and committee
duties, a commitment to representing the best interests of the Company and our stockholders and a dedication to enhancing stockholder
value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Risk
Oversight.&#160;</i>Our Board oversees the management of risks inherent in the operation of our business and the implementation of our
business strategies. Our Board performs this oversight role by using several different levels of review. In connection with its reviews
of the operations and corporate functions of our Company, our Board addresses the primary risks associated with those operations and corporate
functions. In addition, our Board reviews the risks associated with our Company&#8217;s business strategies periodically throughout the
year as part of its consideration of undertaking any such business strategies. Each of our Board committees also coordinates oversight
of the management of our risk that falls within the committee&#8217;s areas of responsibility. In performing this function, each committee
has full access to management, as well as the ability to engage advisors. The Board is also provided with updates by the Chief Executive
Officer and other executive officers of the Company on a regular basis.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Stockholder
Communications. </i>Although we do not have a formal policy regarding communications with the Board, Stockholders may communicate with
the Board by writing to us at 4016 Raintree Rd, Chesapeake, VA 23321, Attention: Chairman. Stockholders who would like their submission
directed to a member of the Board may so specify, and the communication will be forwarded, as appropriate. Please note that the foregoing
communication procedure does not apply to (i) stockholder proposals pursuant to Exchange Act Rule 14a-8 and communications made in connection
with such proposals or (ii) service of process or any other notice in a legal proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Board and Committee
Meetings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the fiscal year ended December 31, 2024, our Board held six meetings and operated primarily by unanimous written consent. For the fiscal
year ended December 31, 2024, our Board was composed of five members from January 1, 2024 to August 14, 2024 and four members from August
15, 2024 to December 31, 2024. Our Audit Committee held four meetings during the year ended December 31, 2024. Our Compensation Committee
and Nominating and Corporate Governance committee held four meetings during the fiscal year ended December 31, 2024. Our Sustainability
Committee held four meetings during the year ended December 31, 2024&#160;.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Board Committees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
December 9, 2015, our Board designated the following three committees of the Board: the Audit Committee, the Compensation Committee, and
the Nominating and Corporate Governance Committee. On September 13, 2022, the Board created a Sustainability Committee of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Audit Committee</i></b><i>.</i>
&#160;The Audit Committee consists of Cheryl Lanthorn and Lisa Lucas-Burke. Cheryl Lanthorn is the Chairperson of the Audit Committee.
The Audit Committee is responsible for, among other things, overseeing the financial reporting and audit process and evaluating our internal
controls over financial reporting. The Board has determined that Cheryl Lanthorn is an &#8220;audit committee financial expert&#8221;
serving on its Audit Committee. The Board has determined that each member of the Audit Committee is &#8220;independent,&#8221; as that
term is defined by applicable SEC rules. In addition, the Board has determined that each member of the Audit Committee is &#8220;independent,&#8221;
as that term is defined by the rules of Nasdaq. A copy of the Audit Committee Charter is available on our website at&#160;<i>https://www.GWAV.com/audit-committee-charter</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Compensation Committee</i></b><i>.
</i>The Compensation Committee consists of Cheryl Lanthorn and Lisa Lucas-Burke. Effective July 12, 2023, Cheryl Lanthorn was appointed
as Chairwoman of the Compensation Committee. Cheryl Lanthorn is the Chairwoman of the Compensation Committee. The Compensation Committee
is responsible for, among other things, establishing and overseeing the Company&#8217;s executive and equity compensation programs, reviewing
and recommending executive officer employment agreements, determining director compensation programs, overseeing the hiring of independent
compensation consultants, preparing the compensation committee report, establishing performance goals and objectives, and evaluating performance
against such goals and objectives. The Compensation Committee also grants stock options and other awards under our stock plans, periodically
reviews the operation of the Company&#8217;s employee benefit plans and analyzes the Company&#8217;s bylaws, Compensation Committee Charter
for its adequacy in meeting the Company&#8217;s compensation-related goals and objectives. The Compensation Committee Charter does not
grant the right to delegate authority to other persons, although it does grant the Compensation Committee the flexibility to hire compensation
consultants to assist in the design, formulation, analysis and implementation of compensation programs for the Company&#8217;s executive
officers. While the Board does not provide a formal role for executive officers in determining or recommending the amount or form of executive
and director compensation, the Compensation Committee meets with the CEO at or near the start of each fiscal year to discuss the goals
and incentive compensation programs. The Board has determined that each member of the Compensation Committee is &#8220;independent,&#8221;
as that term is defined by applicable SEC rules. In addition, the Board has determined that each member of the Compensation Committee
is &#8220;independent,&#8221; as that term is defined by the rules of the Nasdaq Stock Market. A copy of the Compensation Committee Charter
is available on our website at&#160;<i>https://www.GWAV.com/compensation-committee-charter</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Nominating and Corporate
Governance Committee</i></b><i>. </i>As of January 1, 2023, Bryan Plumlee, Cheryl Lanthorn and John Wood served as members of the Nominating
and Corporate Governance Committee. Effective July 12, 2023, Mr. Plumlee resigned from the Nominating and Corporate Governance Committee
and Henry Sicignano was appointed to the Nominating and Corporate Governance Committee. Effective August 7, 2023, Jason Adelman was appointed
to the Nominating and Corporate Governance Committee. Effective August 14, 2024, John Wood resigned from the Nominating and Corporate
Governance Committee. Effective January 28, 2025, Lisa Lucas-Burke was appointed to the Nominating and Corporate Governance Committee.
Cheryl Lanthorn is the Chairwoman of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee
is responsible for, among other things, identifying and recommending candidates to fill vacancies occurring between annual stockholder
meetings and reviewing the Company&#8217;s policies and programs relating to matters of corporate citizenship, including public issues
of significance to the Company and its stockholders. The Board has determined that each member of the Nominating and Corporate Governance
Committee is &#8220;independent,&#8221; as that term is defined by applicable SEC rules. In addition, the Board has determined that each
member of the Nominating and Corporate Governance Committee is &#8220;independent,&#8221; as that term is defined by the rules of the
Nasdaq Stock Market. A copy of the Nominating and Corporate Governance Committee Charter is available on our website at <i>https://www.GWAV.com/ncg-charter</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Sustainability Committee</i></b><i>.
</i>The Sustainability Committee consists of Cheryl Lanthorn and Lisa Lucas-Burke as members of the Sustainability Committee. Cheryl Lanthorn
is the Chairwoman of the Sustainability Committee. The Sustainability Committee is responsible for, among other things, setting and overseeing
the Company&#8217;s goals, strategies, and commitments related to sustainability and Environmental Social Governance, including climate
risks and opportunities, community and social impact, and diversity and inclusion. A copy of the Sustainability Committee Charter is available
on our website at&#160;<i>https://www.GWAV.com/sustainability-committee-charter</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Oversight</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board is primarily responsible
for overseeing our risk management processes. The Board receives and reviews periodic reports from management, auditors, legal counsel
and others, as appropriate, regarding the Company&#8217;s assessment of risks. The Board focuses on the most significant risks facing
the Company and our general risk management strategy, and also ensures that the risks we undertake are consistent with the Board&#8217;s
risk parameters. While the Board oversees the risk management process, our management is responsible for day-to-day risk management and,
if management identifies new or additional significant risks, it brings such risks to the attention of the Board.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Leadership Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Danny
Meeks is the Chairman of our Board and Chief Executive Officer of the Company. The Chairman of the Board presides at all meetings of the
Board, unless such position is vacant, in which case, the Chief Executive Officer of the Company would preside.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policy on Hedging the Economic Risks of Equity
Ownership</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no policy
regarding hedging the economic risks of equity ownership for the executive team or directors of the Company and the Company does not engage
in this practice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes to security holder director nomination
procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has not adopted
procedures for considering director candidates submitted by stockholders under Item 407(c)(2)(iv), Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Delinquent Section 16(a) Reports</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16(a) of the Exchange
Act requires our directors and executive officers and persons who beneficially own more than 10% of our outstanding shares of Common Stock
(collectively, &#8220;Reporting Persons&#8221;) to file with the SEC initial reports of ownership and reports of changes in ownership
in our Common Stock and other equity securities. Such persons are required by SEC regulations to furnish to us copies of all Section 16(a)
forms they file. To our knowledge, based solely on our review of copies of the reports received by us or written representations from
certain Reporting Persons that no other reports were required, we believe that during the fiscal year ended December 31, 2024, all filing
requirements applicable to the Reporting Persons were timely met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXECUTIVE OFFICERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following are biographical
summaries of our executive officers and their ages, except for Mr. Meeks, whose biography is set forth above:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%; text-align: center"><span style="font-size: 10pt">Danny Meeks</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font-size: 10pt">52</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 51%; text-align: center"><span style="font-size: 10pt">Chief Executive Officer and Chairman of the Board</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>Danny
Meeks, Chief Executive Officer, and Chairman of the Board &#8211; </b>Mr. Meeks&#8217; Biographical information is provided above under
&#8220;<i>Proposal One: Election of Directors</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Named Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
named executive officers for the year ended December 31, 2024 were Danny Meeks, our Chief Executive Officer, Ashley Sickles, our former
Chief Financial Officer, and Isaac Dietrich, our Chief Financial Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
following table presents the compensation awarded to, earned by or paid to our named executive officers for the years ended December 31,
2024 and December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Name and Principal Position</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Salary<br/> ($)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Bonus<br/> ($)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Stock<br/> awards<br/> ($) (1)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Option<br/> awards<br/> ($) (1)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nonequity<br/> incentive<br/> plan<br/> compensation<br/> ($)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nonqualified<br/> deferred<br/> compensation<br/> earnings <br/> ($)(3)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">All other<br/> compensation<br/> ($)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total <br/> ($)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; font-size: 10pt; text-align: left">Danny Meeks,</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 6%; font-size: 10pt; text-align: center">2024</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">28,864</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">321,154</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">150,000</td><td style="width: 1%; font-size: 10pt; text-align: left">(4)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 6%; font-size: 10pt; text-align: right">500,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-style: italic; text-align: left">Chief Executive Officer</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">2023</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">500,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">250,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">750,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Ashley Sickles,</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">2024</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-style: italic; text-align: left">Former Chief Financial Officer</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">2023</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">45,173</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">45,173</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Isaac Dietrich,</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">2024</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">64,624</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">230,100</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">93,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">387,724</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-style: italic; text-align: left">Former Chief Financial Officer</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">2023</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">228,093</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">228,093</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(1) These amounts are
the aggregate fair value of the equity compensation incurred by the Company for payments to executives during the fiscal year. The aggregate
fair value is computed in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 718. The fair market value was calculated using the Black-Scholes options pricing model.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) In 2024, our CEO deferred a portion of his
salary not paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Includes $38,000 attributed to the personal
use of a car, $23,700 in reimbursed travel expenses, and a $10,000 business clothing allowance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Narrative Disclosure to the Summary Compensation
Table</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Danny Meeks</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 30, 2021, the
Company entered into an employment agreement with Danny Meeks pursuant to which Mr. Meeks serves as the Company&#8217;s Chief Executive
Officer. Pursuant to the terms of the employment agreement, Mr. Meeks shall receive an annual base salary of $500,000. In addition, Mr.
Meeks shall be eligible to receive an annual bonus and shall be eligible to receive such awards under the Company&#8217;s incentive plans
as determined by the Company&#8217;s Compensation Committee. Mr. Meeks may be terminated by the Company or may voluntarily resign, at
any time, with or without cause. Either the Company or Mr. Meeks may terminate Mr. Meeks&#8217; employment upon two weeks prior written
notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until October 1, 2026, for
every $1 million in annual revenue Empire Services, Inc., a Virginia corporation and wholly owned subsidiary of the Company, generates
over $20 million, Mr. Meeks shall be entitled to receive either 833,333 shares of the Company&#8217;s common stock or $50,000 in cash,
at the discretion of Mr. Meeks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon termination except by
death (the &#8220;Termination Date&#8221;), the Company shall pay Mr. Meeks (i) any accrued but unpaid compensation, (ii) a pro-rata portion
of his annual bonus calculated as of the Termination Date and (iii) reimbursement of expenses incurred on or prior to the Termination
Date. In addition, Mr. Meeks may elect to receive Consolidated Omnibus Budget Reconciliation Act of 1985 benefits for up to twelve months
from the Termination Date. Upon termination of Mr. Meeks&#8217; employment for death, the Company shall pay Mr. Meeks (i) any accrued
but unpaid compensation and (ii) reimbursement of expenses incurred on or prior to such date. Mr. Meeks is also entitled to participate
in any and all benefit plans such as health, dental and life insurance, from time to time, in effect for senior executives, along with
vacation, sick and holiday pay in accordance with the Company&#8217;s policies established and in effect from time to time. In the fiscal
years ended December 31, 2024 and December 31, 2023, Mr. Meeks received $0 and $250,000 in bonuses, respectively. Mr. Meeks did not receive
any compensation related to his position as a director. As of December 31, 2024 and 2023, Mr. Meeks was owed $950,000 and $950,000 in
accrued but unpaid bonuses, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Howard Jordan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 18, 2022, the Company
hired Howard Jordan as Chief Financial Officer, for which he received a salary of $135,000 per year. On September 12, 2022, the Company
terminated Mr. Jordan&#8217;s employment as Chief Financial Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Ashley Sickles</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 13, 2022, the
Company hired Ashley Sickles as Chief Financial Officer, for which she received a salary of $135,000 per year. On April 28, 2023, Ms.
Sickles resigned her position as the Company&#8217;s Chief Financial Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Isaac Dietrich</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 28, 2023, the Company
hired Isaac Dietrich as Chief Financial Officer, for which he received a salary of $300,000 per year. On April 12, 2025, the Company&#160;terminated
the employment of Isaac Dietrich, our Chief Financial Officer, effective April 12, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At no time during the periods
listed in the above tables, with respect to any named executive officers, was there:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any outstanding option or other equity-based award re-priced or otherwise materially modified (such as
by extension of exercise periods, the change of vesting or forfeiture conditions, the change or elimination of applicable performance
criteria, or the change of the bases upon which returns are determined);</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any waiver or modification of any specified performance target, goal or condition to payout with respect
to any amount included in non-stock incentive plan compensation or payouts; or</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any non-equity incentive plan award made to a named executive officer.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nonqualified Deferred Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2024, our CEO deferred a portion of his salary not paid by the Company, as disclosed in the table above. Such payments were deferred
because timely payments further jeopardize the Company&#8217;s ability to continue as a going concern. The Company intends to make such
payments as soon as it is able.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Outstanding Equity
Awards at December 31, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The following table sets forth information regarding
the outstanding equity awards held by our NEOs as of December 31, 2024:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Option Awards</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Stock Awards</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">Name</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Underlying</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unexercised</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(#)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Exercisable</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Underlying</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unexercised</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(#)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unexercisable</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Incentive</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Awards:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Underlying</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unexercised</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unearned</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(#)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Expiration</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Date</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Shares or</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Units of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>That Have</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not Vested</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(#)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Market</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Value of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Shares or</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Units of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>That Have</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not Vested</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Incentive</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Awards:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unearned</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Shares,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Units or</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Rights</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>That Have</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not Vested</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(#)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Incentive</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Awards:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Market</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>or Payout</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Value of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unearned</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Shares,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Units or</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Rights That</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Have Not</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Vested</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 10%; font-size: 10pt; text-align: justify">Isaac Dietrich</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">150,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">105,450</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Timing of Equity Awards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_90F_eecd--AwardTmgMnpiDiscTextBlock_c20240101__20241231_zLhCo3xtc6Yk" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000014" name="ecd:AwardTmgMnpiDiscTextBlock">The Compensation Committee
<span id="xdx_90B_eecd--AwardTmgMnpiCnsdrdFlag_dbT_c20240101__20241231_zeOS5nWSXW6g" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000015" name="ecd:AwardTmgMnpiCnsdrdFlag">grants</ix:nonNumeric></span> equity awards, including stock options, from time to time. This may also include grants in connection with a new hire, promotion,
and other circumstances where the Compensation Committee deems it appropriate to make such grants. Although we have not adopted a formal
policy regarding the timing of equity award grants, including stock options, <span id="xdx_907_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240101__20241231_zB4OCqwRsD5i" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000016" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock">the Compensation Committee does not take material nonpublic
information into account when determining the terms of equity awards and has <span id="xdx_904_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240101__20241231_zT1WYMoraLV3" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000017" name="ecd:MnpiDiscTimedForCompValFlag">not</ix:nonNumeric></span> timed grants or the disclosure of material nonpublic
information for the purpose of affecting the value of executive compensation.</ix:nonNumeric></span> During 2024, there were no stock option awards granted to
any named executive officer within four business days preceding, or one business day after, the filing of any report on Forms 10-K, 10-Q,
or 8-K that disclosed material nonpublic information.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b></b></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Pay Versus Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
August 2022, the SEC adopted final rules to require companies to disclose information about the relationship between executive compensation
actually paid and certain financial performance of the company. The information below is provided pursuant to Item 402(v) of SEC Regulation
S-K with respect to &#8220;smaller reporting companies&#8221; as that term is defined in Item 10(f)(1) of SEC Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000019" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eecd--PvpTableTextBlock_zkYTrcOhNe41" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(a) Year</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--PeoTotalCompAmt_z0sNFLrbyGAf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(b)
    Summary Comp Table Total for PEO ($)<span id="xdx_F5B_zM0r9eOsAgic">(1)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_487_eecd--PeoActuallyPaidCompAmt_zygQ7o5JvcTb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(c)
    Comp. Actually Paid to PEO ($)<span id="xdx_F53_zqDEgFTQAnAe">(2)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_484_eecd--NonPeoNeoAvgTotalCompAmt_zvXNinSDa907" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(d)
    Average Summary Comp. Table for Non-PEO NEOs ($)<span id="xdx_F5E_zI51QnZXlAte">(3)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48B_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z1ZHANHXJmw1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(e)
    Average Comp. Actually Paid to Non-PEO NEOs ($)<span id="xdx_F5A_zGhlNv2pBT7k">(4)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48C_eecd--TotalShareholderRtnAmt_pid_zzh56EkUd8aj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(f)
    Value of Initial Fixed $100 Investment Based On Total Shareholder Return ($)<span id="xdx_F56_zlMNqEMOxo6l">(5)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48E_eus-gaap--NetIncomeLoss_iN_di_z6T2btPPQNMj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(g)
    Net Income ($)<span id="xdx_F55_zXZRzdZ7ErEc">(6)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_41B_20220101__20221231_z1pepCliqkgk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 10%; font-size: 10pt; text-align: center">2022</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,950,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,950,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,942</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,942</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">6.25</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,859,328</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_412_20230101__20231231_zP5BhrH87Nhg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,633</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,633</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">4.01</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,597,142</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_417_20240101__20241231_zxTBgxdIdIik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: center">2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,150,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,150,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">407,625</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">407,625</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000036" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">0.03</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,446,189</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F04_zNRJgU39JDMa" style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/><td id="xdx_F1E_z6fKE6ttpnAc" style="text-align: justify"><ix:footnote id="Footnote000038" xml:lang="en-US">The dollar amounts reported in column (b) are the amounts of total compensation reported
for <span id="xdx_90E_eecd--PeoName_c20240101__20241231_zuZQYeE2PzU6"><span id="xdx_90F_eecd--PeoName_c20230101__20231231_zYHzSn68Hu0g"><span id="xdx_90B_eecd--PeoName_c20220101__20221231_z1ms0M3HVtRa"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000039" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-31" id="Fact000040" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact000041" name="ecd:PeoName">Mr. Meeks</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span> (Chief Executive Officer) from January 2022 to December 2024 for each corresponding year in the &#8220;Total&#8221; column
of the Summary Compensation Table. See &#8220;Executive Compensation - Summary Compensation Table.&#8221;</ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0A_zUguPvJZgPaa" style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/><td id="xdx_F16_zIM4URF9QKdl" style="text-align: justify"><ix:footnote id="Footnote000042" xml:lang="en-US">The dollar amounts reported in column (c) represent the amount of &#8220;compensation actually
paid&#8221; to Mr. Meeks as computed in accordance with Item 402(v)(2)(iii) of SEC Regulation S-K, which prescribes certain specified
additions and subtractions from the amount in column (b). In accordance with the requirements of Item 401(v)(2)(iii) of Regulation S-K,
there were no adjustments required to be made to Mr. Meeks&#8217; total compensation for each year to determine the compensation actually
paid. As of December 31, 2024 and 2023, Mr. Meeks was owed $0 and $1,200,000 in accrued bonuses, respectively.</ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F04_zFgWUlAmYEZ6" style="width: 15pt; text-align: right">(3)</td><td style="width: 5pt"/><td id="xdx_F13_z2KaW78BGXVb" style="text-align: justify"><ix:footnote id="Footnote000043" xml:lang="en-US">The dollar amounts reported in column (d) represent the average amounts reported for the
Company&#8217;s named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich after April 2023) in the &#8220;Total&#8221;
column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Mr. Meeks
and Mr. Dietrich except after April 2023) included for purposes of calculating the average amounts in each applicable year are as follows:
(a) Mr. Dietrich from April 2023 to December 2024; (b) Mr. Jordan from April to September 2022; and (c) Mrs. Sickles from September 2022
to April 2023.</ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0B_z8v0Ja0ElJWg" style="width: 15pt; text-align: right">(4)</td><td style="width: 5pt"/><td id="xdx_F12_zQASAs2t7XCi" style="text-align: justify"><ix:footnote id="Footnote000044" xml:lang="en-US">The dollar amounts reported in column (e) represent the average amount of &#8220;compensation
actually paid&#8221; to the named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich except after April 2023) as computed
in accordance with Item 402(v)(2)(iii) of SEC Regulation S-K, which prescribes certain specified additions and subtractions from the
amount in column (d). In accordance with the requirements of Item 401(v) of Regulation S-K, the following adjustments were made to average
total compensation for the named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich except after April 2023) for each
year to determine the compensation actually paid:</ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0F_zH8Zg8vsgjwg" style="width: 15pt; text-align: right">(5)</td><td style="width: 5pt"/><td id="xdx_F10_zM5M3Z6UGPo1" style="text-align: justify"><ix:footnote id="Footnote000045" xml:lang="en-US">Total Shareholder Return is determined based on the value of an initial fixed investment
in the Company&#8217;s common stock of $100 on December 31, 2021 and calculated in accordance with Item 201(e) of SEC Regulation S-K.</ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F05_z4hssHBcFUq6" style="width: 15pt; text-align: right">(6)</td><td style="width: 5pt"/><td id="xdx_F1A_z21n5MmrH8V7" style="text-align: justify"><ix:footnote id="Footnote000046" xml:lang="en-US">The dollar amounts reported in column (g) represent the amount of net income reflected in
our consolidated audited financial statements for the applicable year.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Analysis of the Information
Presented in the Pay Versus Performance Table</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Compensation Committee of the Board of Directors of the Company does not have a policy or practice regarding evaluating Total Shareholder
Return as part of its determination of compensation decisions for the named executive officers. The Compensation Committee takes various
factors into account in determining the competitiveness of its executive compensation. Over the past three fiscal years the Compensation
Committee has recognized the significant time and effort required by the executive officers and others to manage the Company&#8217;s liquidity
by raising capital while reducing operating expenses and cash used in operations, secure and maintain the Company&#8217;s listing on the
Nasdaq Capital Market, and to source and evaluate merger and acquisition opportunities. To retain qualified executive management, the
Board, from 2022 to 2024, paid bonuses to Mr. Meeks that were earned during fiscal year 2022 through 2024. Mr. Meeks last received equity
awards in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
information provided above under the &#8220;Pay Versus Performance Information&#8221; heading will not be deemed to be incorporated by
reference in any filing of our company under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), whether made before
or after the date hereof and irrespective of any general incorporation language in any such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table presents the total compensation
for each person who served as a non-employee director of our Board during the fiscal year ended December 31, 2024. Other than as set forth
in the table and described more fully below, we did not pay any compensation, reimburse any expense of, make any equity awards or non-equity
awards to, or pay any other compensation to any of the other members of our Board in such period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>Name</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Fees Earned</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>or Paid in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Cash<br/> ($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Awards<br/> ($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Awards ($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>All Other</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Compensation ($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total<br/> ($)</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; font-size: 10pt; text-align: justify">Cheryl Lanthorn</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">50,000</td><td style="width: 1%; font-size: 10pt; text-align: left"><sup>(1)</sup></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">93,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">128,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Henry Sicignano, III<sup>(2)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">93,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">143,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Jason Adelman<sup>(3)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">67,500</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">93,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">160,500</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">John Wood<sup>(4)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">34,375</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">34,375</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">186,875</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">279,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">465,875</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(1) As of December
31, 2024, $15,000 is owed to Mrs. Lanthorn.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(2) Mr. Sicignano,
III resigned from the Board effective February 14, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(3) Mr. Adelman
resigned from the Board effective April 10, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4pt">(4) Mr. Wood resigned
from the Bord effective August 14, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Indemnification of
Officers and Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Second Amended and Restated
Certificate of Incorporation provides that we shall indemnify our officers and directors to the fullest extent permitted by applicable
law against all liability and loss suffered and expenses (including attorneys&#8217; fees) incurred in connection with actions or proceedings
brought against them by reason of their serving or having served as officers, directors or in other capacities. We shall be required to
indemnify a director or officer in connection with an action or proceeding commenced by such director or officer only if the commencement
of such action or proceeding by the director or officer was authorized in advance by the Board of Directors.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Our Equity Incentive
Plans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Stockholders approved
our 2014 Equity Incentive Plan (&#8220;2014 Plan&#8221;) in June 2014, our 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;) in
December 2015, our 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;) in October 2016, our 2017 Equity Incentive Plan (&#8220;2017 Plan&#8221;)
in December 2016, our 2018 Equity Incentive Plan (&#8220;2018 Plan&#8221;) in June 2018, our 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;)
in September 2021, our 2022 Equity Incentive Plan (&#8220;2022 Plan&#8221;) in November 2022, our 2023 Equity Incentive Plan (&#8220;2023
Plan&#8221;) in October 2023, and our 2024 Equity Incentive Plan (&#8220;2024 Plan&#8221; and together with the 2014 Plan, 2015 Plan,
2016 Plan, 2017 Plan, 2018 Plan, 2021 Plan, 2022 Plan, and 2023 Plan, the &#8220;Plans&#8221;) in May 2024, which was subsequently amended
in July 2024. The Plans are identical, except for the number of shares of Common Stock reserved for issuance under each.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Plans provide for the
grant of incentive stock options, non-statutory stock options, stock bonus awards, restricted stock awards, performance stock awards and
other forms of stock compensation to our employees, including officers, consultants and directors. Our Plans also provide that the grant
of performance stock awards may be paid out in cash as determined by the Committee (as defined herein).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Equity Compensation Plan Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table and information
below sets forth information as of December 31, 2024 with respect to our Plans:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of <br/> securities <br/> to be issued <br/> upon <br/> exercise of <br/> outstanding options, <br/> warrants and rights<br/> (a)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted- <br/> average exercise <br/> price of <br/> outstanding <br/> options, <br/> warrants and <br/> rights <br/> (b)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of <br/> securities <br/> remaining available for <br/> future issuance under <br/> equity compensation plans <br/> (excluding securities <br/> reflected in column <br/> (a) (c)</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left">Equity compensation plans approved by security holders</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 14%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 14%; font-size: 10pt; text-align: right">803,272</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by security holders</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">803,272</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Summary of the
Plans</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Authorized Shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">No shares of our Common Stock are reserved for
issuance pursuant to the 2014 Plan, 2015 Plan, the 2016 Plan, the 2017 Plan, the 2018 Plan, the 2021 Plan, 2022 Plan, or 2023 Plan. There
are currently 5 shares of our Common Stock available for issuance pursuant to the 2018 Plan, 1,112 shares of our Common Stock available
for issuance pursuant to the 2021 Plan, 327 shares of our Common Stock available for issuance pursuant to the 2022 Plan, 1,828 shares
of our Common Stock available for issuance pursuant to the 2023 Plan, and 800,000 shares of our Common Stock available for issuance pursuant
to the 2024 Plan. Shares of Common Stock issued under our Plans may be authorized but unissued or reacquired shares of our Common Stock.
Shares of Common Stock subject to stock awards granted under our Plans that expire or terminate without being exercised in full, or that
are paid out in cash rather than in shares of Common Stock, will not reduce the number of shares of Common Stock available for issuance
under our Plans. Additionally, shares of Common Stock issued pursuant to stock awards under our Plans that we repurchase or that are forfeited,
as well as shares of Common Stock reacquired by us as consideration for the exercise or purchase price of a stock award, will become available
for future grant under our Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Administration</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board, or a duly authorized
committee thereof (collectively, the &#8220;Committee&#8221;), has the authority to administer our Plans. Our Board may also delegate
to one or more of our officers the authority to designate employees other than Directors and officers to receive specified stock, which,
in respect to those awards, said officer or officers shall then have all authority that the Committee would have.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms of our
Plans, the Committee has the authority to determine the terms of awards, including recipients, the exercise price or strike price of stock
awards, if any, the number of shares of Common Stock subject to each stock award, the fair market value of a share of our Common Stock,
the vesting schedule applicable to the awards, together with any vesting acceleration, the form of consideration, if any, payable upon
exercise or settlement of the stock award and the terms and conditions of the award agreements for use under the Plans. The Committee
has the power to modify outstanding awards under the Plans, subject to the terms of the Plans and applicable law. Subject to the terms
of our Plans, the Committee has the authority to reprice any outstanding option or stock appreciation right, cancel and re-grant any outstanding
option or stock appreciation right in exchange for new stock awards, cash or other consideration, or take any other action that is treated
as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Stock Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Stock
options may be granted under the Plans. The exercise price of options granted under our Plans must at least be equal to the fair market
value of our Common Stock on the date of grant. The term of an ISO may not exceed 10 years, except that with respect to any participant
who owns more than 10% of the voting power of all classes of our outstanding stock, the term must not exceed 5 years and the exercise
price must equal at least 110% of the fair market value on the grant date. The Committee will determine the methods of payment of the
exercise price of an option, which may include cash, shares of Common Stock or other property acceptable to the Committee, as well as
other types of consideration permitted by applicable law. No single participant may receive more than 25% of the total options awarded
in any single year. Subject to the provisions of our Plans, the Committee determines the other terms of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Performance Shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Performance
shares may be granted under our Plans. Performance shares are awards that will result in a payment to a participant only if performance
goals established by the administrator are achieved or the awards otherwise vest. The Committee will establish organizational or individual
performance goals or other vesting criteria in its discretion, which, depending on the extent to which they are met, will determine the
number and/or the value of performance shares to be paid out to participants. After the grant of a performance share, the Committee, in
its sole discretion, may reduce or waive any performance criteria or other vesting provisions for such performance shares. The Committee,
in its sole discretion, may pay earned performance units or performance shares in the form of cash, in shares of Common Stock or in some
combination thereof, per the terms of the agreement approved by the Committee and delivered to the participant. Such agreement will state
all terms and conditions of the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Restricted Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
terms and conditions of any restricted stock awards granted to a participant will be set forth in an award agreement and, subject to the
provisions in the Plans, will be determined by the Committee. Under a restricted stock award, we issue shares of our Common Stock to the
recipient of the award, subject to vesting conditions and transfer restrictions that lapse over time or upon achievement of performance
conditions. The Committee will determine the vesting schedule and performance objectives, if any, applicable to each restricted stock
award. Unless the Committee determines otherwise, the recipient may vote and receive dividends on shares of restricted stock issued under
our Plans.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Other Share-Based
Awards and Cash Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee may make other
forms of equity-based awards under our Plans, including, for example, deferred shares, stock bonus awards and dividend equivalent awards.
In addition, our Plans authorize us to make annual and other cash incentive awards based on achieving performance goals that are pre-established
by our compensation committee.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Merger, Consolidation
or Asset Sale</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
the Company is merged or consolidated with another entity or sells or otherwise disposes of substantially all of its assets to another
company while awards or options remain outstanding under the Plans, unless provisions are made in connection with such transaction for
the continuance of the Plans and/or the assumption or substitution of such awards or options with new options or stock awards covering
the stock of the successor company, or parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares
and prices, then all outstanding options and stock awards which have not been continued, assumed or for which a substituted award has
not been granted shall, whether or not vested or then exercisable, unless otherwise specified in the relevant agreements, terminate immediately
as of the effective date of any such merger, consolidation or sale.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Change in Capitalization</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
the Company shall effect a subdivision or consolidation of shares of Common Stock or other capital readjustment, the payment of a stock
dividend, or other increase or reduction of the number of shares of Common Stock outstanding, without receiving consideration therefore
in money, services or property, then awards amounts, type, limitations, and other relevant consideration shall be appropriately and proportionately
adjusted. The Committee shall make such adjustments, and its determinations shall be final, binding and conclusive.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Plan Amendment or
Termination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has the authority
to amend, suspend, or terminate our Plans, provided that such action does not materially impair the existing rights of any participant
without such participant&#8217;s written consent. Each of the Plans will terminate ten years after the earlier of (i) the date that each
such Plan is adopted by the Board, or (ii) the date that each such Plan is approved by the Stockholders, except that awards that are granted
under the applicable Plan prior to its termination will continue to be administered under the terms of the that Plan until the awards
terminate, expire or are exercised.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
AND DIRECTOR INDEPENDENCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except for the below, from
January 1, 2023 through the date of this proxy statement, we have not been a party to any transaction or proposed transaction in which
the amount involved in the transaction exceeds the lesser of&#8201; $120,000 or 1% of the average of our total assets at year-end for
the last two completed fiscal years, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of
more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect
material interest, other than equity and other compensation which are described elsewhere in this proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Agreements with Danny
Meeks and Affiliates of Danny Meeks</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Leases for Properties
Underlying Scrap Yards</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 1, 2023, the Company entered into a lease agreement for the Company&#8217;s Chesapeake location with an entity controlled by the
Company&#8217;s Chief Executive Officer. Under the terms of the lease agreement, the Company pays $9,000 per month in rent, increasing
3% on January 1<sup>st</sup>&#160;of each year. The lease expires on January 1, 2025 and the Company has two options to extend the lease
by a term of five years per option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the years ended December 31, 2024 and 2023, the Company leased 12 scrap yard facilities and equipment from an entity controlled by the
Company&#8217;s Chief Executive Officer, including the lease for the Chesapeake location described above for $1,502,830 and $1,640,912,
respectively. As of December 31, 2024 and December 31, 2023, the Company owed $495,354 and $2,070,402, respectively, in accrued rent and
reimbursements to an entity controlled by the Company&#8217;s Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Retirement of Series
Z Preferred</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
July 28, 2023, the Company issued 6,757 shares of common stock to the Company&#8217;s Chief Executive Officer for the exchange of 250
shares of Series Z preferred stock.<i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Assignment of Note
Concurrent with Senior Secured Debt Placement</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
July 31, 2023, the Company assigned the remaining balance of $523,303 of a secured promissory note to DWM Properties, LLC, which is controlled
by the Company&#8217;s Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><i><span style="text-decoration: underline">Sale
of Shredders and Downstream System to the Company</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">On July 31,
2023, the Company entered into a secured promissory note with an entity controlled by the Company&#8217;s Chief Executive Officer in the
principal amount of $17,218,350. The note was for the purchase of certain equipment from an entity controlled by the Company&#8217;s Chief
Executive Officer and is secured by such equipment. There were non-cash proceeds of $17,218,350 used to purchase equipment. The note is
junior to the senior secured debt entered into by the Company on the same date. The note matures on July 31, 2043 and accrues interest
at 7% per annum. The note requires interest-only payments until the senior secured debt is fully satisfied. The Company made payments
of $0 and $498,625&#160;towards the principal and interest, respectively, during the years ended December 31, 2024 and 2023, respectively.
On March 29, 2024, the holder of the note exchanged $10,000,000 in principal for 1,000 shares of Series D Preferred Stock (see&#160;<i>Note
14 &#8211; Stockholders&#8217; Equity</i>). On April 21, 2024, the holder of the note exchanged $7,218,350 in principal for 412,360 shares
of common stock (see&#160;<i>Note 14 &#8211; Stockholders&#8217; Equity</i>). As of December 31, 2024 and 2023, the note had a balance
of $0 and $17,218,350, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">On May 10,
2024, the Company entered into an exchange agreement with DWM, whereby the Company and DWM agreed to exchange 1,000 shares of the Company&#8217;s
Series D issued by the Company to DWM, for 1,333,333 shares of the Company&#8217;s common stock. As a result of the transaction, the Series
D stock was extinguished. The resulting gain on the transaction of $1,224,400 for the difference between the fair value of the common
stock and the carrying value of the Series D was recorded as a contribution of capital as the transaction was between related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Sale of Equipment
to the Company</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">On
June 5, 2024, the Company entered into a Bill of Sale with DWM Properties LLC, an entity wholly-owned by Danny Meeks, the Company&#8217;s
Chief Executive Officer, pursuant to which the Company agreed to purchase certain vehicles held by DWM in exchange for $3,582,181. The
equipment included 27 trucks which enabled the Company to rapidly expand its fleet of trucks offering hauling services to clients, as
well as transporting its scrap metal products to customers. The Company has recorded the equipment on its financial statements at its
cost basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Sale of Properties
Underlying Scrap Yards to the Company</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 2, 2024, the Company
entered into a Contract of Sale (the &#8220;Contract of Sale&#8221;) with DWM Properties LLC (&#8220;DWM&#8221;), KPAJ, LLC and Oceana
Salvage Properties, L.L.C. (collectively, the &#8220;Sellers&#8221;), in each case, an entity affiliated with Danny Meeks, the Company&#8217;s
Chief Executive Officer, pursuant to which the Company agreed to purchase the Premises (as defined in the Contract of Sale) held by the
Sellers for an aggregate purchase price of $15,000,000, to be allocated among the seven parcels comprising the Premises and the Licenses
and Permits (as defined in the Contract of Sale), as more fully described in the Contract of Sale. The transaction closed on December
2, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price is payable
by (i) the issuance of an aggregate of 450,000 shares of Series A-1 Preferred Stock of the Company, par value $0.001 per share (the &#8220;Preferred
Stock&#8221;), to the Sellers at an aggregate valuation of $3,300,084 and (ii) the issuance of a promissory note payable to DWM (the &#8220;DWM
Note&#8221;) in the aggregate principal amount of $11,699,916. The DWM Note bears interest at a rate of 10% per annum, and is payable
in equal installments of $2,983,309 on each of December 31, 2024, January 31, 2025, February 28, 2025 and March 31, 2025 (each, a &#8220;Payment
Date&#8221;); provided, that if payment on a Payment Date would cause the Company&#8217;s cash balance to be less than $3,000,000, then
such Payment Date and each subsequent Payment Date shall be extended by 30 days. The Company shall make all payments owed under the DWM
Note within 12 months from the date of issuance. In addition, if the Company exercises a 30 day extension of any payment, the Company
is required to furnish to DWM such financial information and data as DWM may reasonably request to confirm the Company&#8217;s cash balance.
The Company made payments of $4,008,057 towards the principal, during the year ended December 31, 2024. As of December 31, 2024 and 2023,
the note had a principal balance and accrued interest of $7,691,859 and $0, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><i><span style="text-decoration: underline">Related-Party
Hauling, Mechanic, Equipment Rental, and Miscellaneous Services</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the years ended December 31, 2024 and 2023, the Company provided $850,737 and $68,485, respectively, in hauling services to an entity
controlled by the Company&#8217;s Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the years ended December 31, 2024 and 2023, the Company paid an entity controlled by the Company&#8217;s Chief Executive Officer $1,396,330
and $409,556, respectively, for hauling services rendered to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the year ended December 31, 2024, the Company paid entities controlled by the Company&#8217;s Chief Executive Officer $147,401 for scrap
metal provided to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the year ended December 31, 2024, the Company paid an entity controlled by the Company&#8217;s Chief Executive Officer $847,326 for mechanic
and repair services provided to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the year ended December 31, 2024, the Company paid an entity controlled by the Company&#8217;s Chief Executive Officer $506,358 for equipment
rentals provided to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the year ended December 31, 2023, the Company paid an entity controlled by the Company&#8217;s Chief Executive Officer $29,635 for materials
sold to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Insurance Payment
Made on Behalf of the Company</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the year ended December 31, 2023, an entity controlled by the Company&#8217;s Chief Executive Officer made an insurance down payment of
$105,000 and debt payments of $189,615 on behalf of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Related Party Transaction
Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Audit Committee Charter provides that our Audit Committee will be responsible for reviewing and approving in advance any related party
transaction. Transactions requiring such pre-approval will include, with certain exceptions set forth in Item 404 of Regulation S-K, any
transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are
to be a participant, where the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest,
including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has
a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Audit Committee has reviewed and approved the transactions described in &#8220;Agreements with Danny Meeks and Affiliates of Danny Meeks&#8221;
above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>PROPOSAL TWO:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RATIFICATION OF THE APPOINTMENT OF RBSM LLP
AS THE COMPANY&#8217;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Board has appointed RBSM LLP (&#8220;RBSM&#8221;) as our independent registered public accounting firm to audit our financial statements
for the fiscal year ending December 31, 2025. The Board proposes that our Stockholders ratify this appointment. RBSM has served as our
independent registered public accounting firm since December 28, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect that representatives of RBSM will be available via phone at the Annual Meeting, will be able to make a statement if they so desire,
and will be available to respond to appropriate questions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholder ratification of
the selection of RBSM as our independent registered public accounting firm is not required by our Bylaws or the Delaware General Corporation
Law. The Board seeks such ratification as a matter of good corporate practice. Should the stockholders fail to ratify the selection of
RBSM as our independent registered public accounting firm, the Board will reconsider whether to retain RBSM for fiscal year 2025. In deciding
whether to appoint RBSM, the Audit Committee reviewed auditor independence issues and existing commercial relationships with RBSM and
concluded that RBSM has no commercial relationships with the Company that would impair its independence for the fiscal year ending December
31, 2025. Set forth below are approximate fees paid for services rendered by RBSM for the fiscal years ended December 31, 2024 and December
31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">RBSM</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-size: 10pt; text-align: left">Audit Fees</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">350,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">340,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Audit-Related Fees</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Tax Fees</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other Fees</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Totals</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">350,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">340,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Audit Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
aggregate fees billed for each of the last two fiscal years for professional services rendered by RBSM for the audit of the Company&#8217;s
annual financial statements and review of financial statements included in the Company&#8217;s annual report on Form 10-K and in the Company&#8217;s
quarterly reports on Form 10-Q, or services that are normally provided by the independent registered public accounting firm in connection
with statutory and regulatory filings or engagements for the fiscal years ending December 31, 2024 and 2023 were $350,000 and $340,000,
respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Audit-Related Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate fees billed
in either of the last two fiscal years for assurance and related services by RBSM that are reasonably related to the performance of the
audit or review of the registrant&#8217;s financial statements and are not reported under &#8220;Audit Fees&#8221; for the fiscal years
ending December 31, 2024 and 2023 were $0 and $0, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Tax Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
aggregate fees were billed for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning
for the fiscal years ending December 31, 2024 and 2023 were $0 and $0, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>All Other Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other fees billed for professional
services provided by the principal accountant, other than the services reported above, for the fiscal years ending December 31, 2024 and
2023 were $0 and $0, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee pre-approves
all audit services and permitted non-audit services (including the fees and terms thereof) to be performed for us by our independent registered
public accounting firm, subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(B) of the Exchange
Act and Rule 2-01(c)(7)(i)(C) of Regulation S-X, provided that all such excepted services are subsequently approved prior to the completion
of the audit. We have complied with the procedures set forth above, and the Audit Committee has otherwise complied with the provisions
of its charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required and
Board of Directors&#8217; Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required
to ratify the appointment of RBSM as our independent registered public accounting firm for the fiscal year ending December 31, 2025. We
are not required to obtain the approval of our Stockholders to appoint the Company&#8217;s independent registered public accounting firm.
However, if our Stockholders do not ratify the appointment of RBSM as the Company&#8217;s independent registered public accounting firm
for the fiscal year ending December 31, 2025, the Board may reconsider its appointment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>THE BOARD RECOMMENDS
A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; THE RATIFICATION OF THE APPOINTMENT OF RBSM AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL
YEAR ENDED DECEMBER 31, 2025, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE
ON THEIR PROXY CARD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>REPORT OF THE AUDIT
COMMITTEE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewed and discussed the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2024 with management;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 56.25pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">discussed with the Company&#8217;s independent auditors the matters required to be discussed under Public Company Accounting Oversight
Board Auditing Standard No. 1301; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 56.25pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">received the written disclosures and letter from the independent auditors required by the applicable requirements of the Public Accounting
Oversight Board regarding the independent auditors communications with the Board concerning independence, and has discussed with RBSM
matters relating to its independence.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In reliance on the review
and discussions referred to above, the Board recommended that the consolidated financial statements audited by RBSM for the fiscal year
ended December 31, 2024 be included in its Annual Report on Form 10-K for such fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 56.25pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 56.25pt"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>PROPOSAL THREE:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NON-BINDING ADVISORY VOTE ON THE APPROVAL OF
EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Dodd-Frank Wall Street
Reform and Consumer Protection Act of 2010 and Section 14A of the Exchange Act entitle our Stockholders to vote to approve, on an advisory
and non-binding basis, the compensation of our named executive officers as disclosed in this Proxy Statement pursuant to SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive compensation
programs are designed to (1) motivate and retain executive officers, (2) reward the achievement of our short-term and long-term performance
goals, (3) establish an appropriate relationship between executive pay and short-term and long-term performance, and (4) align executive
officers&#8217; interests with those of our Stockholders. Please read the section of this Proxy Statement entitled &#8220;Executive Compensation&#8221;
for additional details about our executive compensation programs, including information about the fiscal year 2024 compensation of our
named executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
continually reviews the compensation programs for our executive officers to ensure they achieve the desired goals of aligning our executive
compensation structure with our Stockholders&#8217; interests and current market practices. During the fiscal year 2024, our Compensation
Committee was comprised of four members from January to August 2024 and three members from August to December 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking our Stockholders
to indicate their support for our named executive officers&#8217; compensation as disclosed in this Proxy Statement and the accompanying
Annual Report. This proposal, commonly known as a &#8220;say-on-pay&#8221; proposal, gives our Stockholders the opportunity to express
their views on our executive compensation. This vote is not intended to address any specific item of compensation, but rather the overall
compensation of our named executive officers and the philosophy, policies and practices described in this Proxy Statement and the accompanying
Annual Report. Accordingly, we are asking our Stockholders to vote &#8220;FOR&#8221; the following resolution at the Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;RESOLVED, that the
compensation paid to Greenwave Technology Solutions, Inc.&#8217;s named executive officers, as disclosed in Greenwave&#8217;s Proxy Statement
for the 2025 Annual Meeting of Stockholders and the accompanying Annual Report on Form 10-K for the fiscal year ended December 31, 2024
pursuant to Item 402 of Regulation S-K, including the compensation tables and narrative discussion, is hereby APPROVED.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Vote Required and Board of Directors&#8217;
Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To be approved, this non-binding
vote must be approved by a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter
at the Annual Meeting. The say-on-pay vote is advisory, and therefore not binding on the Compensation Committee or the Board. The Board
and the Compensation Committee value the opinions of our Stockholders and to the extent there is any significant vote against the named
executive officers&#8217; compensation as disclosed in this Proxy Statement and the accompanying Annual Report, we will consider our Stockholders&#8217;
concerns and evaluate whether any actions are necessary to address those concerns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>THE BOARD RECOMMENDS
A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; THE PROPOSAL TO APPROVE THE COMPENSATION OF THE COMPANY&#8217;S NAMED EXECUTIVE OFFICERS AS DESCRIBED
UNDER THE HEADING &#8220;EXECUTIVE COMPENSATION,&#8221; AND THE RELATED DISCLOSURES CONTAINED IN THIS PROXY STATEMENT, AND PROXIES SOLICITED
BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THEIR PROXY CARD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PROPOSAL
Four:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ADVISORY VOTE ON THE FREQUENCY OF HOLDING AN
ADVISORY VOTE ON EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the advisory
approval of our executive compensation program, we are also holding a non-binding advisory vote by Stockholders on the frequency with
which Stockholders would have an opportunity to hold an advisory vote on our executive compensation program. We have included this proposal
among the items to be considered at the Annual Meeting pursuant to the requirements of Section&#160;14A of the Exchange Act, which requires
us to submit a non-binding, advisory resolution to stockholders at least once every six years to determine whether advisory votes on executive
officer compensation should be held every one, two or three years. In satisfaction of this requirement, stockholders are being asked to
vote on the following advisory resolution:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;RESOLVED, that the
stockholders of the Company advise that an advisory vote with respect to executive officer compensation should be presented every one,
two or three years as reflected by their votes for each of these alternatives in connection with this resolution.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are providing Stockholders
the option of selecting a frequency of one, two or three years, or abstaining. For the following reasons, we recommend that our stockholders
select a frequency of three years. The Board has determined that an advisory vote by the Stockholders on executive compensation that occurs
every three years is the most appropriate for the Company because&#160;we believe that a triennial voting frequency will provide Stockholders
with sufficient time to evaluate the effectiveness of our overall compensation philosophy, policies, and practices in the context of our
long-term business results for the corresponding period, while avoiding over-emphasis on short-term variations in compensation and business
results. &#160;We also believe that a three-year timeframe provides a better opportunity to observe and evaluate the impact of any changes
to our executive compensation policies and practices that have occurred since the last advisory vote. We therefore recommend that our
stockholders select &#8220;Three Years&#8221; when voting on the frequency of advisory votes on executive compensation. Although the advisory
vote is non-binding, our Board will review the results of the vote and take them into account in making a determination concerning the
frequency of future advisory votes on executive compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The option of one year, two
years or three years that receives the highest number of votes cast by Stockholders will be the frequency of the advisory vote on executive
compensation that has been selected by Stockholders. However, because this vote is advisory and not binding on the Board or us, the Board
may decide that it is in the best interests of Stockholders and us to hold an advisory vote on executive compensation more or less frequently
than the option approved by Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE BOARD RECOMMENDS A VOTE FOR A THREE-YEAR
FREQUENCY FOR HOLDING AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PROPOSAL
FIVE:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-transform: uppercase"><b>APPROVAL
of the issuance of warrants to purchase up to an aggregate of 28,644,323 shares of Common Stock, and the issuance of the shares of Common
Stock issuable upon the exercise of such warrants, in accordance with Nasdaq Listing Rule 5635(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is seeking Stockholder
approval, for purposes of complying with Nasdaq Listing Rule 5635(d), for the issuance of warrants to purchase up to an aggregate of 28,644,323
shares of Common Stock and the issuance of the shares of Common Stock upon exercise of such warrants, consisting of (i) up to an aggregate
of 7,544,323 shares of Common Stock issuable upon exercise of certain outstanding warrants issued in a private placement conducted on
January 10, 2025 concurrently with a registered direct offering (the &#8220;January RD Warrants&#8221;); and (ii) up to an aggregate of
21,100,000 shares of Common Stock issuable upon exercise of certain outstanding warrants issued in a private placement conducted on February
10, 2025 concurrently with a registered direct offering (the &#8220;February RD Warrants&#8221; and together with the January RD Warrants,
the &#8220;Warrants&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in this proposal is qualified in its entirety by reference to the full text of the form of the January RD Warrant attached as Exhibit
4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 13, 2025 and the full text of the form of the February
RD Warrant attached as Exhibit 4.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on May 20, 2024. Stockholders
are urged to carefully read these documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrant Issuances</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>January Registered Direct
Offering and Concurrent Private Placement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 10, 2025, the Company
entered into a securities purchase agreement (the &#8220;January RD Purchase Agreement&#8221;) with certain accredited investors, pursuant
to which, the Company sold, and such accredited investors purchased, an aggregate of 7,544,323 shares of Common Stock, in a registered
direct offering, and accompanying January RD Warrants to purchase up to 7,544,323 shares of Common Stock in a concurrent private placement,
for gross proceeds of approximately $4.0 million, before deducting the financial advisor&#8217;s fees and other estimated offering expenses
(the &#8220;January RD Offering&#8221;). The purchase price for each share of Common Stock and the accompanying January RD Warrant was
$0.5302. The transaction closed on January 14, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The January RD Warrants are
exercisable on or after the date of stockholder approval <span style="background-color: white">for the issuance of the January</span>
RD <span style="background-color: white">Warrants and the shares issuable upon exercise of the </span>January RD <span style="background-color: white">Warrants</span>
and have an exercise price of $0.5302 per share. <span style="background-color: white">The </span>January RD <span style="background-color: white">Warrants
will expire five years from the date the Company obtains stockholder approval for the issuance of the January</span> RD <span style="background-color: white">Warrants
and the shares issuable upon exercise of the </span>January RD <span style="background-color: white">Warrants. The</span> January RD <span style="background-color: white">Warrants
can be exercised on a cashless basis while there is no effective registration statement registering, or no current prospectus available
for, the resale of the shares of Common Stock issuable upon exercise of the January RD Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of the January
RD Warrants was made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act for the offer and sale of securities
not involving a public offering, and Regulation D promulgated under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>February Registered
Direct Offering and Concurrent Private Placement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 10, 2025, the
Company entered into a securities purchase agreement (the &#8220;February RD Purchase Agreement&#8221;) with certain accredited investors,
pursuant to which, the Company sold, and such accredited investors purchased, an aggregate of 21,100,000 shares of Common Stock, in a
registered direct offering, and accompanying February RD Warrants to purchase up to 21,100,000 shares of Common Stock in a concurrent
private placement, for gross proceeds of $7,041,070, before deducting the financial advisor&#8217;s fees and other estimated offering
expenses. The purchase price for each share and the accompanying February RD Warrant was $0.3337. The transaction closed on February 11,
2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The February RD Warrants are
exercisable o<span style="background-color: white">n or after the date of stockholder approval and have an exercise price of $15.00 per
share</span>. <span style="background-color: white">The February</span> RD <span style="background-color: white">Warrants will expire
five years from the date the Company obtains stockholder approval for the issuance of the February</span> RD <span style="background-color: white">Warrants
and the shares issuable upon exercise of the February</span> RD <span style="background-color: white">Warrants. The</span> February RD
<span style="background-color: white">Warrants can be exercised on a cashless basis if there is no effective registration statement registering,
or no current prospectus available for, the resale of the shares issuable upon exercise of the </span>February <span style="background-color: white">RD
Warrants. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of the February
RD Warrants was made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act, for the offer and sale of securities
not involving a public offering, and Regulation D promulgated under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors has
determined that the Warrants, and the Company&#8217;s ability to issue Common Stock upon exercise of the Warrants, are in the best interests
of the Company and its Stockholders because the sale of the Warrants provided the Company with significant capital. Accordingly, we are
seeking Stockholder approval of this proposal in order to comply with the terms of the Warrants and Nasdaq Listing Rule 5635(d), to the
extent applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nasdaq Listing Rule 5635(d)
requires stockholder approval in connection with a transaction, other than a public offering, involving the sale or issuance by the issuer
of Common Stock (or securities convertible into or exchangeable for Common Stock) equal to 20% or more of the Common Stock or 20% or more
of the voting power of such company outstanding before the issuance for a price that is less than the lower of: (i) the closing price
of the Common Stock immediately preceding the signing of the binding agreement for the issuance of such securities and (ii) the average
closing price of the Common Stock for the five trading days immediately preceding the signing of the binding agreement for the issuance
of such securities (the &#8220;Minimum Price&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Therefore, the Company is
seeking stockholder approval to issue more than 20% of the Company&#8217;s outstanding Common Stock pursuant to the Warrants (and as aggregated
with those shares of Common Stock that may be issued to such investors) in compliance with Nasdaq Listing Rule 5635(d).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Consequences if this Proposal is Not Approved</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Stockholders do not approve
this proposal, the Company may not be able to issue shares of Common Stock to the investors upon the receipt of a notice of exercise of
the Warrants, thereby requiring the Company to hold another meeting seeking Stockholder approval, costing the Company additional time
and money, or the Company may be required to repay the investors in cash. Accordingly, if Stockholder approval of this proposal is not
obtained, the Company may need to seek alternative sources of financing, which financing may not be available on advantageous terms, or
at all, and which may result in the incurrence of additional transaction expenses. The Company&#8217;s ability to successfully implement
its business plans and ultimately generate value for its Stockholders is dependent on its ability to maximize capital raising opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Adverse Effects of this Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of Common Stock
that would be issuable to the investors upon exercise of the Warrants would have the same rights and privileges as each of our currently
outstanding shares of Common Stock. The issuance to investors of the Warrants or the Common Stock upon exercise of the Warrants will not
affect the rights of the Common Stockholder, but such issuances will have a dilutive effect on the Company&#8217;s existing Common Stockholders,
including the voting power and economic rights of existing Common Stockholders, and may result in a decline in the Company&#8217;s stock
price or greater price volatility. Further, any sales in the public market of the Common Stock issuable to the investors upon exercise
of the Warrants could adversely affect prevailing market prices of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interests of Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&#8217;s directors and executive officers
have no substantial interests, directly or indirectly, in the matters set forth in this proposal except to the extent of their ownership
of shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required and
Board of Directors&#8217; Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The affirmative vote of
a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is
required to approve this proposal.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221;
THE PROPOSAL TO APPROVE THE ISSUANCE OF WARRANTS TO PURCHASE UP TO AN AGGREGATE OF 28,644,323 SHARES OF COMMON STOCK, AND THE ISSUANCE
OF THE SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF SUCH WARRANTS, IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(D), AND PROXIES
SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THEIR PROXY CARD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PROPOSAL
SIX:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>APPROVAL OF THE ISSUANCE OF UP TO AN AGGREGATE
OF 11,346,743 SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF CERTAIN EXISTING WARRANTS THAT WERE AMENDED ON JANUARY 10, 2025 TO, AMONG
OTHER THINGS, INCREASE THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF SUCH WARRANTS, IN ACCORDANCE WITH NASDAQ LISTING
RULE 5635(D)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is seeking Stockholder
approval, for purposes of complying with Nasdaq Listing Rule 5635(d), in connection with the repricing of warrants issued on or about
(a) March 18, 2024 (the &#8220;March Warrants&#8221;), (b) April 22, 2024 (the &#8220;April Warrants&#8221;), and (c) May 16, 2024 (the
&#8220;May Warrants&#8221; and together with the March Warrants and the April Warrants, the &#8220;Existing Warrants&#8221;). Concurrently
with the January RD Offering, on January 10, 2025, the Company and the holders of the Existing Warrants (the &#8220;Existing Holders&#8221;)
agreed to amend the Existing Warrants (collectively, the &#8220;Warrant Amendment&#8221;). The Warrant Amendment amended the Existing
Warrants&#160;to (i) reduce the exercise price of the Existing Warrants from $2.91 to $1.50 per share, (ii) increase the number of shares
issuable upon exercise of the Existing Warrants by 250% (the &#8220;Quantity Adjustment&#8221;), and (iii) remove certain adjustment provisions
in the Existing Warrants in the event of certain dilutive issuances or share combinations. Following the Warrant Amendment, the Existing
Warrants are exercisable for 11,346,743 shares of Common Stock. The shares of Common Stock issuable upon exercise of the Existing Warrants
pursuant to the Quantity Adjustment and the alternative cashless exercise provision pursuant to Section 2(c) of the Existing Warrants
are subject to stockholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in this proposal is qualified in its entirety by reference to the full text of the March Warrants, the April Warrants, the May Warrants
and the form of Warrant Amendment attached as Exhibits 4.1, 4.1, and 4.1 to the Company&#8217;s Current Report on Form 8-K filed with
the SEC on March 18, 2024, the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 22, 2024 and Company&#8217;s Quarterly
Report on Form 10-Q filed with the SEC on May 20, 2024, respectively. Stockholders are urged to carefully read these documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors has
determined that the Existing Warrants, and the Company&#8217;s ability to issue Common Stock upon exercise of the Existing Warrants, are
in the best interests of the Company and its Stockholders because the sale of the Existing Warrants provided the Company with significant
capital. Accordingly, we are seeking Stockholder approval of this proposal in order to comply with the terms of the Existing Warrants,
as amended by the Warrant Amendment, and Nasdaq Listing Rule 5635(d), to the extent applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed
on The Nasdaq Capital Market, and, as such, we are subject to the Nasdaq Listing Rules, including Nasdaq Listing Rule 5635(d).&#160;Nasdaq
Listing Rule 5635(d) requires stockholder approval in connection with a transaction, other than a public offering, involving the sale
or issuance by the issuer of Common Stock (or securities convertible into or exchangeable for Common Stock) equal to 20% or more of the
Common Stock or 20% or more of the voting power of such company outstanding before the issuance for a price that is less than the Minimum
Price. Since the Company previously received stockholder approval for the issuance of Existing Warrants and the issuance of the shares
of Common Stock issuable upon the exercise of the Existing Warrants, Stockholder approval is again required under Nasdaq Listing Rule
5635(d) as a result of the Quantity Adjustment and to permit the issuance of shares Common Stock upon exercise of the Existing Warrants
at the lower exercise price of $1.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Therefore, the Company is
seeking Stockholder approval to issue more than 20% of the Company&#8217;s outstanding Common Stock pursuant to the Existing Warrants,
as amended by the Warrant Amendment (and as aggregated with those shares of Common Stock that may be issued to such investors) in compliance
with Nasdaq Listing Rule 5635(d).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Consequences if this Proposal is Not Approved</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Stockholders do not approve
this proposal, the Company may not be able to issue shares of Common Stock to the investors upon the receipt of a notice of exercise of
the Existing Warrants, thereby requiring the Company to hold another meeting seeking Stockholder approval, costing the Company additional
time and money, or the Company may be required to repay the Existing Holders in cash. Accordingly, if Stockholder approval of this proposal
is not obtained, the Company may need to seek alternative sources of financing, which financing may not be available on advantageous terms,
or at all, and which may result in the incurrence of additional transaction expenses. The Company&#8217;s ability to successfully implement
its business plans and ultimately generate value for its Stockholders is dependent on its ability to maximize capital raising opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Adverse Effects of this Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of Common Stock
that would be issuable to the Existing Holders upon exercise of the Existing Warrants would have the same rights and privileges as each
of our currently outstanding shares of Common Stock. The issuance to Existing Holders of the Existing Warrants or the Common Stock issuable
upon exercise of the Existing Warrants will not affect the rights of the Common Stockholders, but such issuances will have a dilutive
effect on the Company&#8217;s existing Common Stockholders, including the voting power and economic rights of existing Common Stockholders,
and may result in a decline in the Company&#8217;s stock price or greater price volatility. Further, any sales in the public market of
the Common Stock issuable to the Existing Holders upon exercise of the Existing Warrants could adversely affect prevailing market prices
of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interests of Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s directors
and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this proposal except to the
extent of their ownership of shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required and
Board of Directors&#8217; Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">The affirmative vote of
a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is
required to approve this proposal.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221;
THE PROPOSAL TO APPROVE THE ISSUANCE OF 11,346,743 SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THE EXISTING WARRANTS IN ACCORDANCE
WITH NASDAQ LISTING RULE 5635(D), AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED
OTHERWISE ON THEIR PROXY CARD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PROPOSAL
SEVEN:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>TO RATIFY THE TERMS AND ISSUANCE OF OUR SERIES
A-1 PREFERRED STOCK AND TO APPROVE THE ISSUANCE OF 450,000 SHARES OF THE SERIES A-1 PREFERRED STOCK PURSUANT TO THE CONTRACT OF SALE WITH
THE SELLERS, IN EACH CASE, AN ENTITY AFFILIATED WITH DANNY MEEKS, THE COMPANY&#8217;S CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD,
PURSUANT TO WHICH THE COMPANY AGREED TO PURCHASE CERTAIN PREMISES (AS DEFINED IN THE CONTRACT OF SALE) HELD BY THE SELLERS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
Company is seeking Stockholder approval to ratify the terms of the Series A-1 Preferred Stock and, for purposes of complying with Nasdaq
Listing Rule&#160;5635(d), for the issuance </span>of 450,000 shares of the Series A-1 Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in this proposal is qualified in its entirety by reference to the full text of the Certificate of Designations, Preferences and Rights
of Series A-1 Preferred Stock of Greenwave Technology Solutions, Inc. (the &#8220;Series A-1 COD&#8221;) attached as exhibit 3.1 to the
Company&#8217;s Current Report on Form 8-K filed with the SEC on November 18, 2024. Stockholders are urged to read this document carefully.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Background</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 23, 2024, the
Company filed the Series A-1 COD to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State
of Delaware, providing for and authorizing issuance of 450,000 shares of Series A-1 Preferred Stock. On December 2, 2024, the Company
entered into the Contract of Sale, with the Sellers, in each case, an entity affiliated with Danny Meeks, the Company&#8217;s Chief Executive
Officer and Chairman of the Board, pursuant to which the Company agreed to purchase certain Premises (as defined in the Contract of Sale)
held by the Sellers for an aggregate purchase price of $15,000,000, to be allocated among the seven parcels comprising the Premises and
the Licenses and Permits (as defined in the Contract of Sale), as more fully described in the Contract of Sale. The purchase price was
payable by (i) the issuance of an aggregate of 450,000 shares of Series A-1 Preferred Stock to the Sellers at an aggregate valuation of
$3,300,084 and (ii) the issuance of the DWM Note in the aggregate principal amount of $11,699,916. &#160;The transaction closed on December
2, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The above descriptions of
the DWM Note and Contract of Sale do not purport to be complete and are qualified in their entirety by reference to the full text of the
DWM Note and Contract of Sale, which are filed as Exhibits 4.1 and 10.1, respectively, to the Company&#8217;s Current Report on Form 8-K
filed with the SEC on December 2, 2024. Stockholders are urged to read these documents carefully.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Description of the Series A-1 Preferred
Stock</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">The definitive rights and preferences
of the Series&#160;A-1 Preferred Stock are set forth in the Series&#160;A-1 COD. The Series A-1 COD establishes the rights of the Series
A-1 Preferred Stock. The following is a summary of the Series A-1 COD and the rights of the Series&#160;A-1 Preferred Stockholders:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>Designation, Amount,
and Par Value.</i></b>&#160;&#160;&#160;The number of shares of Series A-1 Preferred Stock designated is 450,000. The shares of Series
A-1 Preferred Stock have a par value of $0.001 per share and a stated value of $1,000 per share, subject to adjustment as set forth in
the Series A-1 COD (the &#8220;Stated Value&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>Conversion Rate. </i></b>The
Series A-1 Preferred Stock are convertible into the number of shares of Common Stock (subject to the limitations set forth in the Series
A-1 COD) that constitutes 0.0001% (the &#8220;<span style="text-decoration: underline">Conversion Rate</span>&#8221;) of the then-outstanding shares of Common Stock of the Company
as of the date of the applicable conversion notice, provided, however, that in no case may the total number of shares of Common Stock
converted from the Series A-1 Preferred Stock consist of more than 45% of the Company&#8217;s total authorized shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>Dividends.</i></b>
The Series A-1 Preferred Stockholders are not entitled to receive any dividends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>Liquidation. </i></b>Upon
any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a
&#8220;<span style="text-decoration: underline">Liquidation</span>&#8221;), the Series A-1 Preferred Stockholders will be entitled to receive out of the assets, whether
capital or surplus, of the Company an amount equal to the Stated Value, before any before any distribution or payment is made to the
holders of any Junior Securities (as defined in the Series A-1 COD). If the assets of the Company are insufficient to pay such
amounts in full, then the entire assets to be distributed to the Series A-1 Stockholders will be ratably distributed among them in
accordance with the respective amounts that would be payable on such shares if all the amounts payable were paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>Maximum Percentage. </i></b>
Series&#160;A-1 Preferred Stockholders are prohibited from converting their Series&#160;A-1 Preferred Stock into shares of Common Stock
if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 45% of the number of shares
of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the
Series A-1 Preferred Stock held by a Series A-1 Preferred Stockholder (the &#8220;Series&#160;A-1 Maximum Percentage&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><b><i>Voting Rights. </i></b>Except
as otherwise expressly required by law, the Series A-1 Preferred Stockholders are entitled to vote on all matters submitted to the Common
Stockholders and each share of Series A-1 Preferred Stock is entitled to the number of votes equal to the number of shares of Common Stock
a Series A-1 Preferred Stockholder would be entitled to receive upon conversion of their Series A-1 Preferred Stock in accordance with
the terms of, and subject to the limitations set forth in, the Series A-1 COD, as if converted at no less than $0.3959 per share (subject
to the Series A-1 Maximum Percentage). Except as otherwise required by law, the Series A-1 Preferred Stockholders vote together with the
holders of Common Stock on all matters and do not vote as a separate class.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed
on The Nasdaq Capital Market, and, as such, we are subject to Nasdaq Listing Rule 5635(d).&#160;Nasdaq Listing Rule 5635(d) requires stockholder
approval in connection with a transaction, other than a public offering, involving the sale or issuance by the issuer of Common Stock
(or securities convertible into or exchangeable for Common Stock) equal to 20% or more of the Common Stock or 20% or more of the voting
power of such company outstanding before the issuance for a price that is less than the Minimum Price. We are seeking Stockholder approval
of this proposal in order to satisfy the requirements of Nasdaq Listing Rule 5635(d) with respect to the terms of the Series A-1 Preferred
Stock and the issuance of shares of our Common Stock upon conversion of the Series A-1 Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Consequences if this Proposal is Not Approved</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Stockholders do not approve
this proposal, the Company may not be able to issue shares of Common Stock to the Series A-1 Preferred Stockholders upon the receipt of
a notice of conversion of the Series A-1 Preferred Stock, thereby requiring the Company to hold another meeting seeking Stockholder approval,
costing the Company additional time and money. Accordingly, if Stockholder approval of this proposal is not obtained, the Company may
need to seek alternative sources of financing, which financing may not be available on advantageous terms, or at all, and which may result
in the incurrence of additional transaction expenses. The Company&#8217;s ability to successfully implement its business plans and ultimately
generate value for its Stockholders is dependent on its ability to maximize capital raising opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Adverse Effects of this Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of Common Stock
that would be issuable upon conversion of the Series A-1 Preferred Stock would have the same rights and privileges as each of our currently
outstanding shares of Common Stock. The issuance to Series A-1 Preferred Stockholders of the Common Stock upon conversion of the Series
A-1 Preferred Stock will not affect the rights of the Common Stockholders, but such issuances will have a dilutive effect on the Company&#8217;s
existing Common Stockholders, including the voting power and economic rights of Common Stockholders, and may result in a decline in the
Company&#8217;s stock price or greater price volatility. Further, any sales in the public market of the Company&#8217;s Common Stock issuable
to the Series A-1 Preferred Stockholders upon conversion of the Series A-1 Preferred Stock could adversely affect prevailing market prices
of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interests of Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, Danny Meeks,
the Company&#8217;s Chief Executive Officer and Chairman of the Board, is affiliated with the Sellers in the Contract of Sale. Thus, Mr.
Meeks may be considered to have an indirect substantial financial interest in the matters set forth in this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required and
Board of Directors&#8217; Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a majority of the Shares
present virtually or represented by proxy and entitled to vote on the subject matter at the Annual Meeting is required to approve this
proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221;
THE PROPOSAL TO RATIFY THE TERMS AND APPROVE THE ISSUANCE OF 450,000 SHARES OF THE SERIES A-1 PREFERRED STOCK PURSUANT TO THE CONTRACT
OF SALE WITH THE SELLERS, IN EACH CASE, AN ENTITY AFFILIATED WITH DANNY MEEKS, THE COMPANY&#8217;S CHIEF EXECUTIVE OFFICER AND CHAIRMAN
OF THE BOARD, PURSUANT TO WHICH THE COMPANY AGREED TO PURCHASE CERTAIN PREMISES (AS DEFINED IN THE CONTRACT OF SALE) HELD BY THE SELLERS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PROPOSAL
EIGHT:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>GRANT OF AUTHORITY FOR ONE OR MORE REVERSE SPLITS
OF THE COMPANY&#8217;S COMMON STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors has approved, subject to Stockholder approval, by written consent in lieu of a meeting, a proposal to amend our Certificate
of Incorporation to effect one or more Reverse Stock Splits of all our outstanding shares of Common Stock, at a ratio between 1-for-2
and 1-for-150, to be determined at the discretion of the Board, subject to the Board&#8217;s discretion to abandon such amendment. If
this proposal is approved, the Board may decide not to effect any Reverse Stock Splits if it determines that it is not in the best interests
of the Company to do so. The Board does not currently intend to seek re-approval of a Reverse Stock Split for any delay in implementing
a Reverse Stock Split unless twenty four months have passed from the date of the Record Date (the &#8220;Authorized Period&#8221;). If
the Board determines to implement one or more Reverse Stock Split, such Reverse Stock Split will become effective upon filing a Certificate
of Amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware or at such later date specified
therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The text of the proposed Certificate
of Amendment to our Certificate of Incorporation to effect a Reverse Stock Split is included as <b><span style="text-decoration: underline">Appendix A</span></b> to this Proxy
Statement (subject to any changes required by applicable law and provided that, since Proposals Number Two and this Proposal Number Five
will result in changes to the Certificate of Incorporation, the Company may file one or more amendments with the Delaware Secretary of
State to effect multiple approved proposals).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Approval of the proposal would
permit (but not require) our Board to effect one or more reverse stock splits of our issued and outstanding Common Stock by a ratio of
not less than 1-for-2 and not more than 1-for-150, with the exact ratio to be set at a number within this range as determined by our Board
of Directors in its sole discretion, provided that (X) the Company shall not effect Reverse Stock Splits that, in the aggregate, exceed
1-for-150, and (Y) any Reverse Stock Split is completed no later than the first anniversary of the Record Date. We believe that enabling
our Board of Directors to set the ratio within the stated range will allow the Company to have the flexibility to meets its obligations
and provide us with the flexibility to implement the Reverse Stock Split in a manner designed to maximize the anticipated benefits for
our Stockholders. In determining a ratio, if any, our Board may consider, among other things, factors such as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>the number of shares of Common Stock the Company is obligated to issue or reserve pursuant to any convertible securities of the Company,
including shares of convertible preferred stock;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>The aggregate amount of shares that may be reserved under the 2024 Plan;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>the initial or continuing listing requirements of various stock exchanges;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>the historical trading price and trading volume of our Common Stock;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>the number of shares of our Common Stock issued and outstanding;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>the then-prevailing trading price and trading volume of our Common Stock and the anticipated impact of the Reverse Stock Split on
the trading market for our Common Stock; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>prevailing general market and economic conditions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board reserves the right
to elect to abandon a Reverse Stock Split, including any or all proposed reverse stock split ratios, if it determines, in its sole discretion,
that a Reverse Stock Split is no longer in the best interests of the Company and its Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depending on the ratio for
the Reverse Stock Splits determined by our Board of Directors, if any, no less than two and no more than one hundred and fifty shares
of existing Common Stock, as determined by our Board of Directors, will be combined into one share of Common Stock. The Company shall
not effect Reverse Stock Splits that, in the aggregate, exceed 1-for-150. The Company shall pay Stockholders the fair value of fractions
of a share as of the time when those entitled to receive such fractions are determined. An amendment to our Certificate of Incorporation
to effect a Reverse Stock Split, if any, will include only the reverse split ratio determined by our Board of Directors at that time to
be in the best interests of our Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Reverse Stock Splits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s primary
reason for approving and recommending one or more Reverse Stock Splits is to: (1) satisfy the continued listing requirements of Nasdaq
Capital Market; (2) make the Common Stock more attractive to certain institutional investors which would provide for a stronger investor
base; and (3) decrease our Delaware annual franchise tax, which may be calculated based upon the number of issued shares. The Company
intends to utilize one or more Reverse Stock Splits in order to meet its contractual obligations and retain enough flexibility for future
corporate actions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reducing the number of issued
shares of Common Stock may, absent other factors, increase the per share market price of the Common Stock. The Company believes that the
Reverse Stock Splits may make its Common Stock more attractive to a broader range of investors, as it believes that the current market
price of the Common Stock may prevent certain institutional investors, professional investors and other members of the investing public
from purchasing stock. Many brokerage houses and institutional investors have internal policies and practices that either prohibit them
from investing in low-priced stocks or tend to discourage individual brokers from recommending low-priced stocks to their customers. Furthermore,
some of those policies and practices may function to make the processing of trades in low-priced stocks economically unattractive to brokers.
Moreover, because brokers&#8217; commissions on low-priced stocks generally represent a higher percentage of the stock price than commissions
on higher-priced stocks, the current average price per share of Common Stock can result in individual Stockholders paying transaction
costs representing a higher percentage of their total share value than would be the case if the share price were higher. The Company believes
that the Reverse Stock Splits will make the Common Stock a more attractive and cost effective investment for many investors, which in
turn would enhance the liquidity of the holders of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Potential Consequences of the Reverse Stock
Splits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, other factors, such
as our financial results, market conditions and the market perception of our business may adversely affect the market price of our Common
Stock. As a result, there can be no assurance that the Reverse Stock Splits, if completed, will result in the intended benefits described
above, that the market price of our Common Stock will increase following the Reverse Stock Splits or that the market price of our Common
Stock will not decrease in the future. Additionally, we cannot assure you that the market price per share of our Common Stock after any
Reverse Stock Split will increase in proportion to the reduction in the number of shares of our Common Stock outstanding before any Reverse
Stock Split. Accordingly, the total market capitalization of our Common Stock after any Reverse Stock Split may be lower than the total
market capitalization before such Reverse Stock Split. Moreover, because some investors may view the reverse stock split negatively, we
cannot assure you that the reverse stock split will not adversely impact the market price of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of our Common
Stock will also be based on our performance and other factors, some of which are unrelated to the Reverse Stock Split or the number of
shares outstanding. Furthermore, the liquidity of our Common Stock could be adversely affected by the reduced number of shares that would
be outstanding after the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we believe that the
Reverse Stock Split will be sufficient to maintain our listing on The Nasdaq Stock Market, it is possible that, even if the Reverse Stock
Split results in a closing price for our Common Stock that exceeds $1.00 per share, we may not be able to continue to satisfy the other
criteria for continued listing of our Common Stock on The Nasdaq Stock Market. In addition, as a Delaware corporation, we are required
to pay an annual Delaware franchise tax which is calculated based upon several variables, including a company&#8217;s number of total
outstanding shares as compared to the company&#8217;s number of authorized shares of capital stock. We believe that a decrease in the
number of outstanding shares as a result of any Reverse Stock Split may decrease our annual Delaware franchise tax liability; however,
no assurance can be given that the decrease in outstanding shares will decrease our annual Delaware franchise tax liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Procedure for Implementing a Reverse Stock
Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A Reverse Stock Split would
become effective upon the filing or such later time as specified in the filing (the &#8220;Effective Time&#8221;) of a Certificate of
Amendment to our Certificate of Incorporation with the Delaware Secretary of State. The form of a Certificate of Amendment to our Certificate
of Incorporation effecting a Reverse Stock Split is attached hereto as <b><span style="text-decoration: underline">Appendix A</span></b>. The exact timing of the filing of the
Certificate of Amendment that would effectuate the Reverse Stock Split would be determined by our Board based on its evaluation as to
when such action will be the most advantageous to the Company and our Stockholders. In addition, our Board would reserve the right, without
further action by the Stockholders, to elect not to proceed with a Reverse Stock Split if, at any time prior to filing a Certificate of
Amendment to the Company&#8217;s Certificate of Incorporation to effect a Reverse Stock Split, our Board, in its sole discretion, determines
that it is no longer in our best interest and the best interests of our Stockholders to proceed with a Reverse Stock Split. Our Board
will only have authority to file with the Delaware Secretary of State a Certificate of Amendment effecting a Reverse Stock Split within
one year from the Record Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of the Reverse Stock Split on Holders
of Outstanding Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depending on the ratio for
the Reverse Stock Splits determined by our Board, a minimum of two and a maximum of one hundred shares in aggregate of existing Common
Stock will be combined into one new share of Common Stock. The table below, which except for the final column does not take into account
the Stock Increase Amendment, illustrates the number of shares of Common Stock authorized for issuance following different Reverse Stock
Splits, the approximate number of shares of Common Stock that would remain outstanding following each such Reverse Stock Split, and the
number of unreserved shares of Common Stock available for future issuance following each such Reverse Stock Split. The examples in the
table below for Reverse Stock Splits range from 1-for-2 to 1-for-150, which is the aggregate ratio allowed under this proposal. Any other
ratios selected within such range would result in a number of shares of Common Stock issued and outstanding following the transaction
between 407,796 and 30,584,754 shares. The information in the following table is based on 61,169,509 shares of Common Stock issued and
outstanding as of July 11, 2025 and 555,461,872 shares reserved for future issuance as of July 11, 2025 assuming conversion of all convertible
securities of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Proposed Ratio</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of authorized <br/>
shares of Common Stock</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Approximate Number of Shares of Common Stock Issued and Outstanding Post-Reverse Stock Split</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Approximate Number of Unreserved Shares of Common Stock Available for Future Issuance Assuming Conversion of all Outstanding Convertible Securities Post-Stock Increase Amendment</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-size: 10pt; font-weight: bold">1-for-2</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 16%; font-size: 10pt; text-align: right">1,200,000,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 16%; font-size: 10pt; text-align: right">30,584,754</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 16%; font-size: 10pt; text-align: right">291,684,309</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold">1-for-150</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,200,000,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">407,796</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,889,124</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The actual number of shares
of Common Stock issued and outstanding after giving effect to a Reverse Stock Split, if implemented, will depend on the Reverse Stock
Split ratio and the number of Reverse Stock Splits, if any, that are ultimately determined by our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any Reverse Stock Splits will
affect all holders of our Common Stock uniformly and will not affect any Stockholder&#8217;s percentage ownership interest in the Company,
except as described below in &#8220;Fractional Shares.&#8221; Record holders of Common Stock otherwise entitled to a fractional share
as a result of a Reverse Stock Split will receive a full share rather than a fractional share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event the Company effectuates
one or more Reverse Stock Splits, the Company will be able to issue substantially more Common Stock. Future issuances of Common Stock
or securities convertible into Common Stock will have a significant dilutive effect on the earnings per share, book value per share, voting
power and percentage interest of holdings of current Stockholders. If a Reverse Stock Split is effected, our Stockholders will experience
significant dilution as a result of shares of Common Stock being issued pursuant to our outstanding convertible securities, including
our outstanding convertible preferred stock. Further, due to our need to raise additional capital in order to fund continuing operations,
our Stockholders will also experience significant dilution as a result of shares of Common Stock being issued in connection with future
financings that the Company may complete.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Stock Splits may
result in some Stockholders owning &#8220;odd lots&#8221; of less than 100 shares of Common Stock. Odd lot shares may be more difficult
to sell, and brokerage commissions and other costs of transactions in odd lots are generally somewhat higher than the costs of transactions
in &#8220;round lots&#8221; of even multiples of 100 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the Effective Time,
our Common Stock will have a new Committee on Uniform Securities Identification Procedures (CUSIP) number, which is a number used to identify
our equity securities, and stock certificates with the older CUSIP number will need to be exchanged for stock certificates with the new
CUSIP number by following the procedures described below. After the Reverse Stock Splits, we will continue to be subject to the periodic
reporting and other requirements of the Exchange Act. Bid and ask prices for our Common Stock will continue to be quoted on the Nasdaq
under the symbol &#8220;GWAV.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the effective time of
the Reverse Stock Splits, the post-split market price of our Common Stock may be less than the pre-split price multiplied by the Reverse
Stock Split ratio. In addition, a reduction in number of shares issued may impair the liquidity for our Common Stock, which may reduce
the value of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Going Private Transaction</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the decrease
in the number of outstanding shares of Common Stock following the implementation of the Reverse Stock Split(s), the Board does not intend
for this transaction to be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule 13e-3 of the Exchange
Act and the implementation of the proposed Reverse Stock Split(s) will not cause the Company to go private.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Authorized Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Stock Splits will
not change the number of authorized shares of the Company&#8217;s Common Stock under the Company&#8217;s Certificate of Incorporation.
Because the number of issued and outstanding shares of Common Stock will decrease, the number of shares of Common Stock remaining available
for issuance will increase. Currently, under our Certificate of Incorporation, our authorized capital stock consists of 1,200,000,000
shares of Common Stock. Please see &#8220;Reasons for the Reverse Stock Splits; Potential Consequences of the Reverse Stock Splits&#8221;
for more information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By increasing the number of
authorized but unissued shares of Common Stock, the Reverse Stock Splits could, under certain circumstances, have an anti-takeover effect,
although this is not the intent of the Board. For example, it may be possible for the Board to delay or impede a takeover or transfer
of control of the Company by causing such additional authorized but unissued shares of Common Stock to be issued to holders who might
side with the Board in opposing a takeover bid that the Board determines is not in the best interests of the Company or its Stockholders.
The Reverse Stock Split therefore may have the effect of discouraging unsolicited takeover attempts. By potentially discouraging initiation
of any such unsolicited takeover attempts the Reverse Stock Splits may limit the opportunity for the Company&#8217;s Stockholders to dispose
of their shares at the higher price generally available in takeover attempts or that may be available under a merger proposal. The Reverse
Stock Split may have the effect of permitting the Company&#8217;s current management, including the current Board, to retain its position,
and place it in a better position to resist changes that the Company&#8217;s Stockholders may wish to make if they are dissatisfied with
the conduct of the Company&#8217;s business. However, the Board is not aware of any attempt to take control of the Company and the Board
of Directors has not approved the Reverse Stock Splits with the intent that they be utilized as a type of anti-takeover device.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Beneficial Holders of Common Stock (i.e. Stockholders
who hold in street name)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the implementation of
a Reverse Stock Split, we intend to treat shares held by Stockholders through a bank, broker, custodian or other nominee in the same manner
as registered Stockholders whose shares of Common Stock are registered in their names. Banks, brokers, custodians or other nominees will
be instructed to effect a Reverse Stock Split for their beneficial holders holding our Common Stock in street name. However, these banks,
brokers, custodians or other nominees may have different procedures than registered Stockholders for processing the Reverse Stock Split.
Stockholders who hold shares of our Common Stock with a bank, broker, custodian or other nominee and who have any questions in this regard
are encouraged to contact their banks, brokers, custodians or other nominees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Registered &#8220;Book-Entry&#8221; Holders
of Common Stock (i.e. Stockholders that are registered on the transfer agent&#8217;s books and records but do not hold stock certificates)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain of our registered
holders of Common Stock may hold some or all of their shares electronically in book-entry form with the transfer agent. These Stockholders
do not have stock certificates evidencing their ownership of the Common Stock. They are, however, provided with a statement reflecting
the number of shares registered in their accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders who hold shares
of Common Stock electronically in book-entry form with the transfer agent will not need to take action (the exchange will be automatic)
to receive whole shares of post-Reverse Stock Split Common Stock, subject to adjustment for treatment of fractional shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Holders of Certificated Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders holding shares
of our Common Stock in certificated form will be sent a transmittal letter by our transfer agent after the effective time of the Stock
Split. The letter of transmittal will contain instructions on how a Stockholder should surrender his, her or its certificate(s) representing
shares of our Common Stock (the &#8220;Old Certificates&#8221;) to the transfer agent in exchange for certificates representing the appropriate
number of whole shares of post-Reverse Stock Split Common Stock (the &#8220;New Certificates&#8221;). No New Certificates will be issued
to a Stockholder until such Stockholder has surrendered all Old Certificates, together with a properly completed and executed letter of
transmittal, to the transfer agent. No Stockholder will be required to pay a transfer or other fee to exchange his, her or its Old Certificates.
Stockholders will then receive a New Certificate(s) representing the number of whole shares of Common Stock that they are entitled as
a result of a Reverse Stock Split, subject to the treatment of fractional shares described below. Until surrendered, we will deem outstanding
Old Certificates held by Stockholders to be cancelled and only to represent the number of whole shares of post-Reverse Stock Split Common
Stock to which these Stockholders are entitled, subject to the treatment of fractional shares. Any Old Certificates submitted for exchange,
whether because of a sale, transfer or other disposition of stock, will automatically be exchanged for New Certificates. If an Old Certificate
has a restrictive legend on the back of the Old Certificate(s), the New Certificate will be issued with the same restrictive legends that
are on the back of the Old Certificate(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company expects that our
transfer agent will act as exchange agent for purposes of implementing the exchange of stock certificates. No service charges will be
payable by holders of shares of Common Stock in connection with the exchange of certificates. All of such expenses will be borne by the
Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S)
AND SHOULD NOT SUBMIT ANY STOCK CERTIFICATE(S) UNTIL REQUESTED TO DO SO.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fractional Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not currently
intend to issue fractional shares of Common Stock in connection with any Reverse Stock Split. Therefore, the Company does not expect to
issue certificates representing fractional shares of Common Stock. In lieu of any fractional shares, the Company will issue to stockholders
of record who would otherwise hold a fractional share because the number of shares of common stock they hold of record before the Reverse
Stock Split is not evenly divisible by the Reverse Stock Split ratio that number of shares of common stock, as rounded up to the nearest
whole share. No stockholders will receive cash in lieu of fractional shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not expect
the Reverse Stock Split and the rounding up of fractional shares to whole shares to result in a significant reduction in the number of
record holders. The Company presently does not intend to seek any change in its status as a reporting company for federal securities law
purposes, either before or after the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of the Reverse Stock Split(s) on Employee
Plans, Options, Restricted Stock Awards and Units, Warrants, Convertible or Exchangeable Securities, and Preferred Stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the applicable
Reverse Stock Split ratio determined by the Board of Directors, proportionate adjustments are generally required to be made to the per
share exercise price and the number of shares of Common Stock issuable upon the exercise or conversion of all outstanding options, warrants,
convertible or exchangeable securities, including any preferred stock, entitling the holders to purchase, exchange for, or convert into,
shares of Common Stock. This would result in approximately the same aggregate price being required to be paid under such options, warrants,
convertible or exchangeable securities upon exercise, and approximately the same value of shares of Common Stock being delivered upon
such exercise, exchange or conversion, immediately following such Reverse Stock Split as was the case immediately preceding such Reverse
Stock Split. The number of shares deliverable upon settlement or vesting of restricted stock awards will be similarly adjusted, subject
to our treatment of fractional shares. The number of shares of Common Stock reserved for issuance pursuant to these securities will be
proportionately based upon the Reverse Stock Split ratio determined by the Board, subject to our treatment of fractional shares. In the
event of a Reverse Stock Split, the maximum number of shares that can be issued under the 2021 Plan (including the ISO share grant limit),
the number of shares issued under the 2021 Plan and subject to each award, the exercise prices of outstanding awards, the maximum number
of shares that are reserved under the 2021 Plan, and the number of shares available for issuance under the 2021 Plan, shall each be equitably
and proportionately adjusted by the 2021 Plan Committee (as defined herein).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accounting Matters</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The proposed amendment to
the Company&#8217;s Certificate of Incorporation will not affect the par value of our Common Stock per share, which will remain $0.001
par value per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Federal Income Tax Consequences of
the Reverse Stock Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary describes
certain material U.S. federal income tax consequences of the Reverse Stock Split(s) to holders of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise specifically
indicated herein, this summary addresses the tax consequences only to a beneficial owner of our Common Stock that is (i) a citizen or
individual resident of the United States, (ii) a corporation organized in or under the laws of the United States or any state thereof
or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source;
or (iv) a trust if (1) its administration is subject to the primary supervision of a court within the United States and one or more U.S.
persons have the authority to control all of its substantial decisions, or (2) it has a valid election in effect under applicable U.S.
Treasury regulations to be treated as a U.S. person (a &#8220;U.S. holder&#8221;). This summary does not address all of the tax consequences
that may be relevant to any particular investor, including tax considerations that arise from rules of general application to all taxpayers
or to certain classes of taxpayers or that are generally assumed to be known by investors. In addition, it does not purport to address
all aspects of federal income taxation that may be relevant to Stockholders in light of their particular circumstances or to any Stockholder
that may be subject to special tax rules, including without limitation: (i) persons that may be subject to special treatment under U.S.
federal income tax law, such as banks, insurance companies, thrift institutions, regulated investment companies, real estate investment
trusts, tax-exempt organizations, U.S. expatriates, persons subject to the alternative minimum tax, traders in securities that elect to
mark to market and dealers in securities or currencies, (ii) persons that hold our Common Stock as part of a position in a &#8220;straddle&#8221;
or as part of a &#8220;hedging,&#8221; &#8220;conversion&#8221; or other integrated investment transaction for federal income tax purposes,
or (iii) persons that do not hold our Common Stock as &#8220;capital assets&#8221; (generally, property held for investment).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a partnership (or other
entity classified as a partnership for U.S. federal income tax purposes) is the beneficial owner of our Common Stock, the U.S. federal
income tax treatment of a partner in the partnership will generally depend on the status of the partner and the activities of the partnership.
Partnerships that hold our Common Stock, and partners in such partnerships, should consult their own tax advisors regarding the U.S. federal
income tax consequences of the Reverse Stock Split(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This summary is based on the
provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), U.S. Treasury regulations, administrative rulings
and judicial authority, all as in effect as of the date of this Proxy Statement. Subsequent developments in U.S. federal income tax law,
including changes in law or differing interpretations, which may be applied retroactively, could have a material effect on the U.S. federal
income tax consequences of the Reverse Stock Split(s). There can be no assurance that the Internal Revenue Service will not take a contrary
position to the tax consequences described herein or that such position will be sustained by a court. No opinion of counsel or ruling
from the Internal Revenue Service has been obtained with respect to the U.S. federal income tax consequences of the Reverse Stock Split(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>PLEASE CONSULT YOUR OWN
TAX ADVISOR REGARDING THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN INCOME AND OTHER TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT(S) IN YOUR
PARTICULAR CIRCUMSTANCES UNDER THE INTERNAL REVENUE CODE AND THE LAWS OF ANY OTHER TAXING JURISDICTION.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>U.S. Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the assumption that
the Reverse Stock Split(s) will constitute a tax-free reorganization within the meaning of Section 368(a)(1)(E) of the Code, and subject
to the limitations and qualifications set forth in this discussion, the following is a general discussion of the U.S. federal income tax
consequences relating to the Reverse Stock Split(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the Reverse
Stock Split(s) should be treated as a recapitalization for U.S. federal income tax purposes. Therefore, a U.S. holder generally should
not recognize gain or loss on the Reverse Stock Split(s). The aggregate tax basis of the post-split shares of Common Stock received should
be equal to the aggregate tax basis of the pre-split shares of Common Stock exchanged therefore (excluding any portion of the holder&#8217;s
basis allocated to fractional shares), and the holding period of the post-split shares of Common Stock received will include the holding
period of the pre-split shares of Common Stock exchanged. U.S. holders should consult their tax advisors as to the application of the
foregoing rules where shares of our Common Stock were acquired at different times or at different prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash payments received by
a U.S. holder of our Common Stock pursuant to the Reverse Stock Split(s) may be subject to information reporting, and may be subject to
backup withholding if the U.S. holder fails to provide a valid taxpayer identification number and comply with certain certification procedures
or otherwise establish an exemption from backup withholding. Backup withholding is not an additional tax. Rather, the U.S. federal income
tax liability of the person subject to backup withholding will be reduced by the amount of the tax withheld. If backup withholding results
in an overpayment of taxes, a refund may be obtained provided that the required information is timely furnished to the Internal Revenue
Service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Appraisal Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Delaware law and our
charter documents, holders of our Common Stock will not be entitled to dissenter&#8217;s rights or appraisal rights with respect to any
Reverse Stock Splits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the
Annual Meeting and entitled to vote thereon is required to approve an amendment to the Company&#8217;s Certificate of Incorporation to
approve the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE BOARD RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221;
THE APPROVAL OF THE DISCRETIONARY AUTHORITY TO THE COMPANY&#8217;S BOARD OF DIRECTORS TO AMEND THE CERTIFICATE OF INCORPORATION TO EFFECT
ONE OR MORE REVERSE STOCK SPLITS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PROPOSA
NINE:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>AUTHORIZATION
TO ADJOURN THE ANNUAL MEETING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
the Annual Meeting is convened and a quorum is present, but there are not sufficient votes to approve the forgoing proposals described
in this Proxy Statement, the Company may move to adjourn the Annual Meeting at that time in order to enable our Board to solicit additional
proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
this Proposal Seven, we are asking our Stockholders to authorize the Company to adjourn the Annual Meeting to another time and place,
if necessary or advisable, to solicit additional proxies in the event that there are not sufficient votes to approve the forgoing proposals,
each as described in this Proxy Statement. If our Stockholders approve this proposal, we could adjourn the Annual Meeting and any adjourned
session of the Annual Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from our
Stockholders that have previously voted. Among other things, approval of this proposal could mean that, even if we had received proxies
representing a sufficient number of votes to defeat the forgoing proposals, we could adjourn the Annual Meeting without a vote on such
proposals and seek to convince our Stockholders to change their votes in favor of such proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
it is necessary or advisable to adjourn the Annual Meeting, no notice of the adjourned meeting is required to be given to our Stockholders,
other than an announcement at the Annual Meeting of the time and place to which the Annual Meeting is adjourned, so long as the meeting
is adjourned for 30 days or less and no new record date is fixed for the adjourned meeting. At the adjourned meeting, we may transact
any business which might have been transacted at the original meeting. If, however, after the adjournment, the Board fixes a new record
date for the adjourned meeting, a notice of adjourned meeting shall be provided to each Stockholder of record as of the new record date
and entitled to vote at such meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Vote Required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
affirmative vote of a majority of the Shares present virtually or represented by proxy and entitled to vote on the subject matter at the
Annual Meeting is required to approve this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>OUR BOARD OF DIRECTORS
RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; THE PROPOSAL TO AUTHORIZE THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY OR ADVISABLE.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OTHER MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of the date of this Proxy Statement, the Board knows of no other business that will be presented at the Annual Meeting. If any other business
is properly brought before the Annual Meeting, it is intended that proxies in the enclosed form will be voted in respect thereof in accordance
with the best judgment and in the discretion of the persons voting the proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 50%"><span style="font-size: 10pt">By order of the Board of Directors,</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><i>/s/ Danny Meeks</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Danny Meeks</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer and Chairman of the Board</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chesapeake, VA</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>APPENDIX A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTIFICATE OF AMENDMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE SECOND AMENDED AND RESTATED</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTIFICATE OF INCORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OF</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>GREENWAVE TECHNOLOGY SOLUTIONS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Greenwave Technology Solutions,
Inc. (the &#8220;<b><i>Corporation</i></b>&#8221;), a corporation organized and existing under and by virtue of the General Corporation
Law of the State of Delaware (the &#8220;<b><i>DGCL</i></b>&#8221;), does hereby certify:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIRST. The Second Amended
and Restated Certificate of Incorporation of the Corporation is hereby amended by changing Article Fourth, so that, as amended, the following
shall be added as Section 4.1(e):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;(e) <span style="text-decoration: underline">Reverse
Stock Split</span>. Effective at 11:59 p.m., Eastern Time, on [&#160;&#160;], 2025 (the &#8220;<span style="text-decoration: underline">Reverse Split Effective Time</span>&#8221;),
every [&#160;&#160;] shares of Common Stock issued and outstanding or held by the Corporation as treasury shares as of the Reverse Split
Effective Time shall automatically, and without action on the part of the stockholders, be combined, reclassified and changed into one
(1) validly issued, fully paid and non-assessable share of Common Stock, without effecting a change to the par value per share of Common
Stock, subject to the treatment of fractional interests as described below (the &#8220;<span style="text-decoration: underline">Reverse Split</span>&#8221;). No fractional shares
shall be issued in connection with the exchange. In lieu thereof, any person who holds a fraction of one (1) share of Common Stock after
the exchange shall have their fraction of one (1) share rounded up to the nearest whole fraction of one (1) share of Common Stock. As
of the Reverse Split Effective Time and thereafter, a certificate representing shares of Common Stock prior to the Reverse Split is deemed
to represent the number of post-Reverse Split shares into which the pre-Reverse Split shares were reclassified and combined. The Reverse
Split shall also apply to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Common Stock of
the Corporation and all references to such Common Stock in agreements, arrangements, documents and plans relating thereto, or any option
or right to purchase or acquire shares of Common Stock, shall be deemed to be references to the Common Stock, or options or rights to
purchase or acquire shares of Common Stock, after giving effect to the Reverse Split.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND. That a resolution
was duly adopted by unanimous written consent of the directors of the Corporation, pursuant to Section 242 of the DGCL, setting forth
the above mentioned amendment to the Second Amended and Restated Certificate of Incorporation and declaring said amendment to be advisable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIRD. Pursuant to the resolution
of the board of directors of the Corporation, a meeting of the stockholders of the Corporation was duly called and held upon notice in
accordance with Section 222 of the DGCL at which meeting the necessary number of shares as required by statute were voted in favor of
the foregoing amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, this Certificate
of Amendment of the Second Amended and Restated Certificate of Incorporation has been signed by the Chief Executive Officer of the Corporation
this [&#160;&#160;] day of [&#160;&#160;], 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-size: 10pt">GREENWAVE TECHNOLOGY SOLUTIONS, INC.</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%">&#160;</td>
    <td style="width: 50%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">Danny Meeks</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>This proxy is solicited on behalf of the Board
of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 56%"><p style="font-size: 14pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 14pt">GREENWAVE TECHNOLOGY SOLUTIONS INC</span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><b></b>4016 Raintree Rd., Ste 300, Chesapeake, VA 23321&#160;</p></td>
  <td style="width: 2%">&#160;</td>
  <td style="width: 42%"><b>VOTE BY INTERNET - www.GWAV.vote</b><br/><p style="font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; margin: 0pt">Use the Internet to vote by proxy up until 7:00
                                                                    P.M. Eastern Time on</p>
                                                                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-top: 3pt">August 12, 2025. Have your proxy card in hand when you access</p>
                                                                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-top: 3pt">the website and then follow the instructions.
                                                                    Enter the 12 digit Control</p>
                                                                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-top: 3pt">Number below and follow the instructions to vote your proxy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>VOTE BY MAIL</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; margin: 0pt">Mark, sign, and date this proxy card and promptly return it to</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-top: 3pt">EQUITY STOCK TRANSFER,</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">237 W 37TH ST, Suite 602, New York, NY 10018,</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ATTN:
Shareholder Services.</p>
<p style="font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; margin: 0pt"><b>VOTE BY FAX or BY EMAIL</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; margin: 0pt">Mark, sign, and date this proxy card and promptly return it</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">by fax: (347)-584-3644 ATTN: Shareholder Services
or</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">by email: <span style="text-decoration: underline">proxy@equitystock.com</span> ATTN: Shareholder Services.</p>
<p style="font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; margin: 0pt"><b>CONTROL#</b></p>
</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The undersigned hereby appoints Danny Meeks, the true and lawful proxy of the undersigned, with full power of substitution, to vote all
shares of the Common Stock, $0.0001 par value per share, of Greenwave Technology Solutions Inc., (the &#8220;Company&#8221;), which the undersigned
is entitled to vote at the annual meeting of stockholders of the Company to be held at 4:30 p.m., Eastern Time, on August 13, 2025, (the
&#8220;Annual Meeting&#8221;) to be held virtually by calling 877-407-3088 (toll free) or +1-877-407-3088 (International), and any adjournment or
adjournment or postponement thereof. There will not be a physical meeting location.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 55%"><b>THE BOARD OF DIRECTORS OF GREENWAVE TECHNOLOGY SOLUTIONS INC. (THE &#8220;COMPANY&#8221;) RECOMMENDS THAT
  YOU VOTE &#8220;FOR&#8221; FOR EACH OF THE NOMINEES IN PROPOSAL 1, &#8220;FOR&#8221; ON PROPOSALS 2, 3, 5, 6, 7 AND 8, AND &#8220;FOR&#8221;
  &#8220;3 YEARS&#8221; ON PROPOSAL 4.</b></td>
  <td style="width: 2%">&#160;</td>
  <td style="width: 43%">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td><b>&#160;</b></td>
    <td>&#160;</td>
  <td><b>&#160;</b></td>
  <td><b>&#160;</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><b>For</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><b>Withhold</b></td>
    <td><b>&#160;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 3%">&#160;</td>
    <td style="width: 3%">1.</td>
  <td style="width: 30%"> Election of three (3) Directors.</td>
  <td style="width: 42%">1a. Danny Meeks</td>
    <td style="width: 7%"><b>&#160;&#160;&#9744;</b></td>
    <td style="width: 8%"><b>&#160;&#160;&#9744;</b></td>
    <td style="width: 7%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td style="padding-left: 0.625in">Nominees:</td>
  <td>&#160;</td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td>
  <td>1b. Cheryl Lanthorn</td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td>
  <td>1c. Lisa Lucas-Burke</td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td>&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%">&#160;</td>
  <td style="width: 70%"><b>&#160;</b></td>
  <td style="width: 2%"><b>&#160;</b></td>
  <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 7%"><b>&#160;</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%"><b>For</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 7%"><b>Against</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>2.</td>
  <td>To ratify the appointment of RBSM LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending
December 31, 2025. </td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>3.</td>
  <td>To approve, on an advisory and non-binding basis, the compensation paid to the Company&#8217;s named executive officers.</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%">&#160;</td>
  <td style="width: 68%"><b>&#160;</b></td>
  <td style="width: 1%"><b>&#160;</b></td>
  <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 6%"><b>3yrs</b></td>
  <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 6%"><b>2yrs</b></td>
  <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 7%"><b>1yr</b></td>
  <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 6%"><b>Abstain</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>4.</td>
  <td>To approve on a non-binding advisory basis the frequency with which the stockholders shall vote to approve executive compensation.</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
  <td><b>&#160;&#160;&#9744;</b></td>
  <td><b>&#160;&#160;&#9744;</b></td>
  <td><b>&#160;&#160;&#9744;</b></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%">&#160;</td>
  <td style="text-align: left; width: 70%"><b>&#160;</b></td>
  <td style="width: 2%"><b>&#160;</b></td>
  <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 7%"><b>For</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%"><b>Against</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 7%"><b>Abstain</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>5.</td>
  <td style="text-align: left">To approve the issuance of warrants to purchase up to an aggregate of 28,644,323 shares of the Company&#8217;s common stock, par value
$0.001 per share (&#8220;Common Stock&#8221;), and the issuance of the shares of Common Stock issuable upon the exercise of such warrants,
in accordance with Listing Rule 5635(d) of The Nasdaq Stock Market LLC (&#8220;Nasdaq Listing Rule 5635(d)&#8221;).</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>6.</td>
  <td style="text-align: left">To approve the issuance of 11,346,743 shares of Common Stock issuable upon exercise of certain existing warrants that were amended on
January 10, 2025, to, among other things, increase the number of shares of Common Stock issuable upon exercise of such warrants, in accordance
with Nasdaq Listing Rule 5635(d).</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>7.</td>
  <td style="text-align: left">To ratify the terms and approve the issuance of 450,000 shares of Series A-1 Convertible Preferred Stock of the Company, par value $0.001
per share (the &#8220;Series A-1 Preferred Stock&#8221;), pursuant to the Contract of Sale, dated December 2, 2024 (the &#8220;Contract
of Sale&#8221;), with DWM Properties LLC, KPAJ, LLC and Oceana Salvage Properties, L.L.C. (collectively, the &#8220;Sellers&#8221;), in
each case, an entity affiliated with Danny Meeks, the Company&#8217;s Chief Executive Officer and Chairman of the Board, pursuant to which
the Company agreed to purchase certain Premises (as defined in the Contract of Sale) held by the Sellers.</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>8.</td>
  <td style="text-align: left">To grant discretionary authority to the Company&#8217;s Board of Directors to amend the Certificate of Incorporation to effect one or
more consolidations of the issued and outstanding shares of Common Stock, pursuant to which the shares of Common Stock would be combined
and reclassified into one share of Common Stock at a ratio within the range from 1-for-2 up to 1-for-150 (each, a &#8220;Reverse Stock
Split&#8221;), provided that, (X) the Company shall not effect Reverse Stock Splits that, in the aggregate, exceed 1-for-150, and (Y)
any Reverse Stock Split is completed no later than the second anniversary of the Record Date (as defined herein);</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b><b>&#160;</b></td>
    <td><b><b>&#160;&#160;&#9744;</b></b></td>
    <td><b>&#160;&#160;&#9744;</b><b>&#160;</b></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>9.</td>
  <td style="text-align: left">To approve the adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposals
if there are not sufficient votes to approve the foregoing proposals.</td>
  <td>&#160;</td>
  <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td>
    <td><b>&#160;&#160;&#9744;</b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If you encounter any technical difficulties with
the virtual meeting platform on the meeting day, please call 877-804-2062 (toll free) or email <span style="text-decoration: underline">proxy@equitystock.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Please sign exactly as your name appears hereon. When signing as attorney, executor, administrator, trustee, guardian, or corporate officer,
please indicate full title as such. Joint owners should each sign personally. All holders must sign. If a corporation, please sign the
full corporate or partnership name, by authorized officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="border: Black 1pt solid; width: 32%"><p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                  <p style="margin-top: 0; margin-bottom: 0">&#160;</p></td>
  <td style="width: 1%">&#160;</td>
  <td style="border: Black 1pt solid; width: 16%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border: Black 1pt solid; width: 32%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border: Black 1pt solid; width: 17%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>Signature [PLEASE SIGN WITHIN BOX]</td>
  <td>&#160;</td>
  <td>Date</td>
  <td>&#160;</td>
  <td>Signature (Joint Owners)</td>
  <td>&#160;</td>
  <td>Date</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 46; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdoVVNidDh3iFBki3haXSXFrRlp/9ki+pXVDDIGQnPPlCDESGa1NjQznZZHDEZu21h6hwAoZ7QWDI91sEwizwKtxnrX1/foDUwoMBmY2jnW4986HcVgmIOeTWE7UFKRK1BwWOxF99ZRsZUq03ugatC3hwNSyQa+5Gz4c9YssNV2fdEJ2hmwC8VgO8huUjBXs6aGfxDcHeZ6KaNRXJDKmextcq5dH+yVhVWMT4txA/zv6AMF9Sks= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>gwav-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWauK6bP9z5Z86ekhvWB6bXnK7ygi7oAcIyzbpxqGoQQD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:GWAV="http://gwav.com/20241231" elementFormDefault="qualified" targetNamespace="http://gwav.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://gwav.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="gwav-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gwav-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gwav-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>gwav-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="gwav-20241231.xsd#Cover" roleURI="http://gwav.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gwav.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>gwav-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="ecd_PayVsPerformanceDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PayVsPerformanceDisclosureLineItems" xlink:to="ecd_PayVsPerformanceDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PayVsPerformanceDisclosureLineItems_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Disclosure - Pay vs Performance Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="ecd_AwardTmgDiscLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgDiscLineItems" xlink:to="ecd_AwardTmgDiscLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgDiscLineItems_lbl" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>gwav-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="gwav-20241231.xsd#Cover" roleURI="http://gwav.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:presentationLink xlink:type="extended" xlink:role="http://gwav.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GREENWAVE
TECHNOLOGY SOLUTIONS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001589149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PayVsPerformanceDisclosureLineItems', window );"><strong>Pay vs Performance Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Disclosure - Pay vs Performance Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eecd--PvpTableTextBlock_zkYTrcOhNe41" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(a) Year</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--PeoTotalCompAmt_z0sNFLrbyGAf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(b)
    Summary Comp Table Total for PEO ($)<span id="xdx_F5B_zM0r9eOsAgic">(1)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_487_eecd--PeoActuallyPaidCompAmt_zygQ7o5JvcTb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(c)
    Comp. Actually Paid to PEO ($)<span id="xdx_F53_zqDEgFTQAnAe">(2)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_484_eecd--NonPeoNeoAvgTotalCompAmt_zvXNinSDa907" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(d)
    Average Summary Comp. Table for Non-PEO NEOs ($)<span id="xdx_F5E_zI51QnZXlAte">(3)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48B_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z1ZHANHXJmw1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(e)
    Average Comp. Actually Paid to Non-PEO NEOs ($)<span id="xdx_F5A_zGhlNv2pBT7k">(4)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48C_eecd--TotalShareholderRtnAmt_pid_zzh56EkUd8aj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(f)
    Value of Initial Fixed $100 Investment Based On Total Shareholder Return ($)<span id="xdx_F56_zlMNqEMOxo6l">(5)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_48E_eus-gaap--NetIncomeLoss_iN_di_z6T2btPPQNMj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(g)
    Net Income ($)<span id="xdx_F55_zXZRzdZ7ErEc">(6)</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_41B_20220101__20221231_z1pepCliqkgk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 10%; font-size: 10pt; text-align: center">2022</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,950,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,950,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">62,942</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">62,942</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">6.25</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">(63,859,328</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_412_20230101__20231231_zP5BhrH87Nhg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">750,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">750,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">136,633</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">136,633</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">4.01</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(33,597,142</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_417_20240101__20241231_zxTBgxdIdIik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: center">2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,150,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,150,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">407,625</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">407,625</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0.03</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(100,446,189</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,150,000<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="nump">$ 1,950,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,150,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">1,950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">407,625<span></span>
</td>
<td class="nump">136,633<span></span>
</td>
<td class="nump">62,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">407,625<span></span>
</td>
<td class="nump">136,633<span></span>
</td>
<td class="nump">62,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.03<span></span>
</td>
<td class="nump">4.01<span></span>
</td>
<td class="nump">6.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">$ (100,446,189)<span></span>
</td>
<td class="num">$ (33,597,142)<span></span>
</td>
<td class="num">$ (63,859,328)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. Meeks<span></span>
</td>
<td class="text">Mr. Meeks<span></span>
</td>
<td class="text">Mr. Meeks<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (b) are the amounts of total compensation reported
for <span id="xdx_90E_eecd--PeoName_c20240101__20241231_zuZQYeE2PzU6"><span id="xdx_90F_eecd--PeoName_c20230101__20231231_zYHzSn68Hu0g"><span id="xdx_90B_eecd--PeoName_c20220101__20221231_z1ms0M3HVtRa">Mr. Meeks</span></span></span> (Chief Executive Officer) from January 2022 to December 2024 for each corresponding year in the &#8220;Total&#8221; column
of the Summary Compensation Table. See &#8220;Executive Compensation - Summary Compensation Table.&#8221;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (c) represent the amount of &#8220;compensation actually
paid&#8221; to Mr. Meeks as computed in accordance with Item 402(v)(2)(iii) of SEC Regulation S-K, which prescribes certain specified
additions and subtractions from the amount in column (b). In accordance with the requirements of Item 401(v)(2)(iii) of Regulation S-K,
there were no adjustments required to be made to Mr. Meeks&#8217; total compensation for each year to determine the compensation actually
paid. As of December 31, 2024 and 2023, Mr. Meeks was owed $0 and $1,200,000 in accrued bonuses, respectively.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (d) represent the average amounts reported for the
Company&#8217;s named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich after April 2023) in the &#8220;Total&#8221;
column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Mr. Meeks
and Mr. Dietrich except after April 2023) included for purposes of calculating the average amounts in each applicable year are as follows:
(a) Mr. Dietrich from April 2023 to December 2024; (b) Mr. Jordan from April to September 2022; and (c) Mrs. Sickles from September 2022
to April 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (e) represent the average amount of &#8220;compensation
actually paid&#8221; to the named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich except after April 2023) as computed
in accordance with Item 402(v)(2)(iii) of SEC Regulation S-K, which prescribes certain specified additions and subtractions from the
amount in column (d). In accordance with the requirements of Item 401(v) of Regulation S-K, the following adjustments were made to average
total compensation for the named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich except after April 2023) for each
year to determine the compensation actually paid:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Total Shareholder Return is determined based on the value of an initial fixed investment
in the Company&#8217;s common stock of $100 on December 31, 2021 and calculated in accordance with Item 201(e) of SEC Regulation S-K.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (g) represent the amount of net income reflected in
our consolidated audited financial statements for the applicable year.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PayVsPerformanceDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PayVsPerformanceDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recovery of Erroneously Awarded Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_RestatementDateAxis=2024-04-16', window );">Restatement Determination Date [Axis]: 2024-04-16</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ErrCompRecoveryTable', window );"><strong>Erroneously Awarded Compensation Recovery [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_RestatementDoesNotRequireRecoveryTextBlock', window );">Restatement Does Not Require Recovery [Text Block]</a></td>
<td class="text">Our Board has adopted a compensation
recovery policy, which provides that in the event we are required to prepare an accounting restatement due to noncompliance with any financial
reporting requirements under the securities laws or otherwise erroneous data or we determine there has been a significant misconduct that
causes financial or reputational harm, we shall recover a portion or all of any incentive compensation. The policy is filed as an exhibit
to this annual report.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ErrCompRecoveryTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 6<br> -Subsection F<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Section 19<br> -Paragraph a<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-CSR<br> -Section 18<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ErrCompRecoveryTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_RestatementDoesNotRequireRecoveryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 6<br> -Subsection F<br> -Paragraph 2<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Section 19<br> -Paragraph b<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-CSR<br> -Section 18<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_RestatementDoesNotRequireRecoveryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_RestatementDateAxis=2024-04-16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_RestatementDateAxis=2024-04-16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure [Text Block]</a></td>
<td class="text">The Compensation Committee
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardTmgMnpiCnsdrdFlag_dbT_c20240101__20241231_zeOS5nWSXW6g">grants</span> equity awards, including stock options, from time to time. This may also include grants in connection with a new hire, promotion,
and other circumstances where the Compensation Committee deems it appropriate to make such grants. Although we have not adopted a formal
policy regarding the timing of equity award grants, including stock options, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_907_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240101__20241231_zB4OCqwRsD5i">the Compensation Committee does not take material nonpublic
information into account when determining the terms of equity awards and has <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240101__20241231_zT1WYMoraLV3">not</span> timed grants or the disclosure of material nonpublic
information for the purpose of affecting the value of executive compensation.</span> During 2024, there were no stock option awards granted to
any named executive officer within four business days preceding, or one business day after, the filing of any report on Forms 10-K, 10-Q,
or 8-K that disclosed material nonpublic information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered [Text Block]</a></td>
<td class="text">the Compensation Committee does not take material nonpublic
information into account when determining the terms of equity awards and has <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240101__20241231_zT1WYMoraLV3">not</span> timed grants or the disclosure of material nonpublic
information for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="formpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gwav.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="formpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995440 - Disclosure - Recovery of Erroneously Awarded Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/ErrCompDisclosure</Role>
      <ShortName>Recovery of Erroneously Awarded Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="formpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="formpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="PRE 14A" isUsgaap="true" original="formpre14a.htm">formpre14a.htm</File>
    <File>gwav-20241231.xsd</File>
    <File>gwav-20241231_def.xml</File>
    <File>gwav-20241231_lab.xml</File>
    <File>gwav-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "formpre14a.htm": {
   "nsprefix": "GWAV",
   "nsuri": "http://gwav.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "formpre14a.htm"
     ]
    },
    "schema": {
     "local": [
      "gwav-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "gwav-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gwav-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gwav-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 88,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 25,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://gwav.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
     "longName": "995440 - Disclosure - Recovery of Erroneously Awarded Compensation",
     "shortName": "Recovery of Erroneously Awarded Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2024-01-012024-12-31_2024-04-16",
      "name": "ecd:RestatementDoesNotRequireRecoveryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_2024-04-16",
      "name": "ecd:RestatementDoesNotRequireRecoveryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formpre14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r41",
      "r51",
      "r61",
      "r86"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r44",
      "r54",
      "r64",
      "r89"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r82",
      "r90",
      "r94",
      "r102"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r100"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://gwav.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://gwav.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://gwav.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://gwav.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://gwav.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://gwav.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r41",
      "r51",
      "r61",
      "r86"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r48",
      "r58",
      "r83"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r90"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r90"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r90"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r90"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r90"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r82",
      "r90",
      "r94",
      "r102"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r105"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r105"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r105"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income (Loss) Attributable to Parent",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r106"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r43",
      "r53",
      "r63",
      "r88"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r56",
      "r66",
      "r91"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r56",
      "r66",
      "r91"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure - Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r38",
      "r48",
      "r58",
      "r83"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r49",
      "r59",
      "r84"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r50",
      "r60",
      "r85"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r57",
      "r67",
      "r92"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r42",
      "r52",
      "r62",
      "r87"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001641172-25-019514-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-019514-xbrl.zip
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M882,.,6B)Q;"/3XPO8FDAO#SN!+@0%;QK:/ #)_ D[+;18]D&%#JU2"D $M
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M$+LTC1@K%Y5XUI>&<:%PGYY0]0G,+H4PZMF!]P^'7LA?@][9N. !@*MAML.
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M0A[H6]KU7C%V97Y"E7)*;CLT+#6W7MFN3*;A/@ )K;FMK%N2Z^+63#*O34;
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MB$XERN \O3'9R#-N) [-394GK;CO2TI$_.Y+]3!WV+;XG<.T0C G@XYBVW9
M L@D\IR^^9&)%Y[6E;9T6PQ6@664-9.VK/P,\60QD<VH)H13"=NNTK" $8:V
MYVK([+DX)BYA&2L%2R@R4G,I'*"9+6':#D7;(J^'EID/AIGQ0*;#A,^@H BI
M7UQ)3/O 47UWC22@ZACOP1$9PAG)]%Q4?[+/W3S<&S&AJM].4;_#$LJUJ:_
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M\,M]UU_;KFQM/^#Z'ZG[T@,#0+ G$Y&U>H@HP"Z@M BZ\U#8#6N/UUA#_;(
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M<.S&Q%$4/#R3AJ"[TO);K=69FE13FC3#65O=NI,^FDEI^=NKV]*D^K$FUYP
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MM(9+P %;^)XJ/H](V3(.B$1[7%&/,AO#;E(+9!"U-@OC\)+BAR;RZCO@K&@
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M0C\%/ 8A2ANP8!#>S0_#-DD'8987M?0+5W21Q](,+V6&  0T)P1S,&%^0E_
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M//;)?@H$XW6>E9],RC#%1ZTP(<Z(B,R_J=($RX5G)A-> S%=["A)$W/."M0
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M1HL*AI-@M(L=&8SC\\!6CZB^>SXO-=;JK3/"JF6LUGLO:KVH]6:."GJ]TO?
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M?5D##K,102KYW-"%-&'KP+>_96&87*%3X33L721@LYU?>R<I>@>IW?VDMUQ
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M/JBZ>!TRL.,HR+P_$1.VK'OHNL/M#5E.?YYRT_?E?2C><ZTDE%-[F[>&QL.
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M@?PD-A1%-811%^$I?F#$7BNZI15-E1,T!3*L"+B1P95X1<H8J5ET;\V3WR5
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M68QX=<*5A0$5(DE\8A'L$0'S1<;2,#"^N,$$DLA*1>F,AWQ9-P/8W0_. %/
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M!>BN]0C;: Q1X1ATW/-AFR8#% R!+Z.\)**F54CRB/,MQ-<7Q@_Y><\%87B
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MXY.#3G5\8[W_YVK#.MC]T/X9_4DK\KX[[$WA_Q?CR\'G_P=02P,$%     @
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MVWV#3W9>_Y8=&O: UBL&7]=W32=14\,_4$L#!!0    ( '*"[EHN!A7S0P,
M /H4   5    9W=A=BTR,#(T,3(S,5]D968N>&ULO9C?;]HP$,??)^U_\++G
M$*#;I-*RBM)U0J+K5&BW5Q,?X-6QD>WPX[^?;1)6&@H)(\D#2NR[[WWLG,TY
MEU?+B*$Y2$4%;WN-6MU#P$-!*)^TO<>!WQET>ST/*8TYP4QP:'M<>%=?W[]#
MYKK\X/OHE@(C+70C0K_'Q^("_< 1M-!WX""Q%O("/6$6VQ9Q2QE(U!71C($&
MT[$.W$)?:@V,?#^'[!-P(N3C0V\C.]5ZIEI!L%@L:ES,\4+(9U4+191/<*"Q
MCM5&K;ZL)]?:_9)1_MRR/R.L )GIXJJU5+3MV;A)V,593<A)T*S7&\'ON_X@
MG$*$?<KMM(7@I5Y699=?X_S\/'"]J6G&<CF2+(UQ%J0X&V732_3&X:7QYV#=
M^=*4[I%^ :UH2[F1]$6(M4N0@T3H30O[Y*=FOFWR&TW_K%%;*N*E[\E-MA0,
M'F",W(RT]&IFDDY1FS->TC:5,&Y[DP6>&Z'FIT9S+?.Q*TPJ>\@*F S9X%I#
MFQ"![0@2H^"HF&FRN;$I"&L3,0\@)('EL#<.R,'\G,]NJ J94+&$7U1/.X10
M.XV8W0&VC2J+FM%UR+FDJAC0$(^L0&[JQ+X*M [Y$RL= ==J*.P6 URYK"V
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M)G>]J;Y:#\)LYAK9N,;TO[#JL4%MO647YJ%?9,R$I+>DC F"N0%&!_>L6(*
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M\<G_ 5!+ 0(4 Q0    ( '*"[EK+/7H GOT   ^H!@ .              "
M 0    !F;W)M<')E,31A+FAT;5!+ 0(4 Q0    ( '*"[EH(4*%T2@,  &H-
M   1              "  <K]  !G=V%V+3(P,C0Q,C,Q+GAS9%!+ 0(4 Q0
M   ( '*"[EHN!A7S0P,  /H4   5              "  4,! 0!G=V%V+3(P
M,C0Q,C,Q7V1E9BYX;6Q02P$"% ,4    " !R@NY:?OG4')T/  #&R@  %0
M            @ &Y! $ 9W=A=BTR,#(T,3(S,5]L86(N>&UL4$L! A0#%
M  @ <H+N6A%_T%IC"P  ZXP  !4              ( !B10! &=W878M,C R
C-#$R,S%?<')E+GAM;%!+!08     !0 % $0!   ?( $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>formpre14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gwav-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001589149</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_2024-04-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001589149</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2024-04-16</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001589149</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001589149</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000004">0001589149</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0010">PRE 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000011">GREENWAVE TECHNOLOGY SOLUTIONS, INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000012">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:RestatementDoesNotRequireRecoveryTextBlock
      contextRef="From2024-01-012024-12-31_2024-04-16"
      id="Fact000013">Our Board has adopted a compensation
recovery policy, which provides that in the event we are required to prepare an accounting restatement due to noncompliance with any financial
reporting requirements under the securities laws or otherwise erroneous data or we determine there has been a significant misconduct that
causes financial or reputational harm, we shall recover a portion or all of any incentive compensation. The policy is filed as an exhibit
to this annual report.</ecd:RestatementDoesNotRequireRecoveryTextBlock>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000014">The Compensation Committee
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardTmgMnpiCnsdrdFlag_dbT_c20240101__20241231_zeOS5nWSXW6g"&gt;grants&lt;/span&gt; equity awards, including stock options, from time to time. This may also include grants in connection with a new hire, promotion,
and other circumstances where the Compensation Committee deems it appropriate to make such grants. Although we have not adopted a formal
policy regarding the timing of equity award grants, including stock options, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_907_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240101__20241231_zB4OCqwRsD5i"&gt;the Compensation Committee does not take material nonpublic
information into account when determining the terms of equity awards and has &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240101__20241231_zT1WYMoraLV3"&gt;not&lt;/span&gt; timed grants or the disclosure of material nonpublic
information for the purpose of affecting the value of executive compensation.&lt;/span&gt; During 2024, there were no stock option awards granted to
any named executive officer within four business days preceding, or one business day after, the filing of any report on Forms 10-K, 10-Q,
or 8-K that disclosed material nonpublic information.</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="From2024-01-01to2024-12-31" id="Fact000015">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000016">the Compensation Committee does not take material nonpublic
information into account when determining the terms of equity awards and has &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240101__20241231_zT1WYMoraLV3"&gt;not&lt;/span&gt; timed grants or the disclosure of material nonpublic
information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="From2024-01-01to2024-12-31" id="Fact000017">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000019">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eecd--PvpTableTextBlock_zkYTrcOhNe41" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(a) Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48D_eecd--PeoTotalCompAmt_z0sNFLrbyGAf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(b)
    Summary Comp Table Total for PEO ($)&lt;span id="xdx_F5B_zM0r9eOsAgic"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_487_eecd--PeoActuallyPaidCompAmt_zygQ7o5JvcTb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(c)
    Comp. Actually Paid to PEO ($)&lt;span id="xdx_F53_zqDEgFTQAnAe"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--NonPeoNeoAvgTotalCompAmt_zvXNinSDa907" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(d)
    Average Summary Comp. Table for Non-PEO NEOs ($)&lt;span id="xdx_F5E_zI51QnZXlAte"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z1ZHANHXJmw1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(e)
    Average Comp. Actually Paid to Non-PEO NEOs ($)&lt;span id="xdx_F5A_zGhlNv2pBT7k"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48C_eecd--TotalShareholderRtnAmt_pid_zzh56EkUd8aj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(f)
    Value of Initial Fixed $100 Investment Based On Total Shareholder Return ($)&lt;span id="xdx_F56_zlMNqEMOxo6l"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eus-gaap--NetIncomeLoss_iN_di_z6T2btPPQNMj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;(g)
    Net Income ($)&lt;span id="xdx_F55_zXZRzdZ7ErEc"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20220101__20221231_z1pepCliqkgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 10%; font-size: 10pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,950,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,950,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;62,942&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;62,942&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;6.25&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;(63,859,328&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20230101__20231231_zP5BhrH87Nhg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;750,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;750,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;136,633&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;136,633&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4.01&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(33,597,142&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20240101__20241231_zxTBgxdIdIik" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,150,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,150,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;407,625&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;407,625&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;0.03&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(100,446,189&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000020"
      unitRef="USD">1950000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000021"
      unitRef="USD">1950000</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">62942</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000023"
      unitRef="USD">62942</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000024"
      unitRef="USD">6.25</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000025"
      unitRef="USD">63859328</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000026"
      unitRef="USD">750000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000027"
      unitRef="USD">750000</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000028"
      unitRef="USD">136633</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">136633</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000030"
      unitRef="USD">4.01</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">33597142</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000032"
      unitRef="USD">2150000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000033"
      unitRef="USD">2150000</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000034"
      unitRef="USD">407625</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000035"
      unitRef="USD">407625</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000036"
      unitRef="USD">0.03</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000037"
      unitRef="USD">100446189</us-gaap:NetIncomeLoss>
    <ecd:PeoName contextRef="From2024-01-01to2024-12-31" id="Fact000039">Mr. Meeks</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-01-012023-12-31" id="Fact000040">Mr. Meeks</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31" id="Fact000041">Mr. Meeks</ecd:PeoName>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnote id="Footnote000038" xlink:label="Footnote000038" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (b) are the amounts of total compensation reported
for <xhtml:span id="xdx_90E_eecd--PeoName_c20240101__20241231_zuZQYeE2PzU6"><xhtml:span id="xdx_90F_eecd--PeoName_c20230101__20231231_zYHzSn68Hu0g"><xhtml:span id="xdx_90B_eecd--PeoName_c20220101__20221231_z1ms0M3HVtRa">Mr. Meeks</xhtml:span></xhtml:span></xhtml:span> (Chief Executive Officer) from January 2022 to December 2024 for each corresponding year in the &#x201c;Total&#x201d; column
of the Summary Compensation Table. See &#x201c;Executive Compensation - Summary Compensation Table.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnote id="Footnote000042" xlink:label="Footnote000042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (c) represent the amount of &#x201c;compensation actually
paid&#x201d; to Mr. Meeks as computed in accordance with Item 402(v)(2)(iii) of SEC Regulation S-K, which prescribes certain specified
additions and subtractions from the amount in column (b). In accordance with the requirements of Item 401(v)(2)(iii) of Regulation S-K,
there were no adjustments required to be made to Mr. Meeks&#x2019; total compensation for each year to determine the compensation actually
paid. As of December 31, 2024 and 2023, Mr. Meeks was owed $0 and $1,200,000 in accrued bonuses, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000043" xlink:label="Footnote000043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (d) represent the average amounts reported for the
Company&#x2019;s named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich after April 2023) in the &#x201c;Total&#x201d;
column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Mr. Meeks
and Mr. Dietrich except after April 2023) included for purposes of calculating the average amounts in each applicable year are as follows:
(a) Mr. Dietrich from April 2023 to December 2024; (b) Mr. Jordan from April to September 2022; and (c) Mrs. Sickles from September 2022
to April 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000034"
          xlink:label="Fact000034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000034"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000044" xlink:label="Footnote000044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (e) represent the average amount of &#x201c;compensation
actually paid&#x201d; to the named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich except after April 2023) as computed
in accordance with Item 402(v)(2)(iii) of SEC Regulation S-K, which prescribes certain specified additions and subtractions from the
amount in column (d). In accordance with the requirements of Item 401(v) of Regulation S-K, the following adjustments were made to average
total compensation for the named executive officers as a group (excluding Mr. Meeks and Mr. Dietrich except after April 2023) for each
year to determine the compensation actually paid:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnote id="Footnote000045" xlink:label="Footnote000045" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Total Shareholder Return is determined based on the value of an initial fixed investment
in the Company&#x2019;s common stock of $100 on December 31, 2021 and calculated in accordance with Item 201(e) of SEC Regulation S-K.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000036"
          xlink:label="Fact000036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnote id="Footnote000046" xlink:label="Footnote000046" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (g) represent the amount of net income reflected in
our consolidated audited financial statements for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
